INsIde thIs Issue - PRWebww1.prweb.com/prfiles/2013/10/04/11197922/CTM_092613web.pdf · OxOnc Development, Proximagen, Skeletal Dynamics and Strati-Health. ... Kline, Hoffmann-La

Highlights of Changes This Week at ClinicalTrials.gov:New Sponsors: Nine sponsors registered studies at ClinicalTri-als.gov for the first time this week. Those sponsors are bioRASI, DiaVacs, inSleep Technologies, MDbackline, Mirabilis Medica, OxOnc Development, Proximagen, Skeletal Dynamics and Strati-Health. For more details, see New Sponsors on Page 2.

New Studies: One hundred and six new studies were registered this week, including studies sponsored by AbbVie, Allergan, AstraZen-eca, Baxter, Bayer, Boehringer Ingelheim, Celgene, Eli Lilly, Glaxo- SmithKline, Hoffmann-La Roche, Janssen, Medtronic, Merck, Novartis, Onyx, Pfizer, Sanofi Pasteur, Takeda and Vertex. For more details, see New Studies on Page 3.

New Results: Twenty-eight industry-sponsored studies posted results this week, including studies by Allergan, Amgen, Astellas, AstraZeneca, Eisai, Gilead, GlaxoSmithKline, Merck, Pfizer and Teva. For more details, see New Results on Page 7.

New Study Status: One hundred and fifty-four studies are report-ing changes in their status as planning, recruiting, ongoing or com-pleted this week. Among the sponsors are AbbVie, Amgen, Astel-las, AstraZeneca, Bayer, Boehringer Ingelheim, Cubist, Eli Lilly, Exelixis, Genentech, Gilead, GlaxoSmithKline, Hoffmann-La Roche, Janssen, MedImmune, Medtronic, Merck, Novartis, Novo

Vol. 2, No. 39Sept. 26, 2013

New Sponsors ..........Page 2

New Studies .............Page 3

New Results .............Page 7

New Study Status .....Page 8

Studies Opening a First Site in a New Country ...Page 15

Studies Opening Additional Sites in a Country ..Page 24

Study Sites by Country ..................Page 50

Studies Under Planning .................Page 51

Studies Ended or Halted .....................Page 63

INsIde thIs Issue

Summary of laTeST Trial updaTeS

Week ending Sept. 26 Sept. 19 Sept. 12 Sept. 5 Total

New Sponsors 9 16 12 6 43New Studies 106 108 101 81 384New Results 28 24 23 26 102New Study Status 154 147 171 78 573Studies Opening a First Site in a New Country 211 237 227 195 899Studies Opening Additional Sites in a Country 586 325 707 338 2,015Studies Under Planning 301 284 275 45 906Studies Ended or Halted 15 18 16 11 72

(See Highlights, Page 2)

CliniCal Trial Magnifier Weekly Sept. 26, 2013page 2

Nordisk, Otsuka, Pfizer, Sandoz, Sanofi, Takeda and Vertex. For more details, see New Study Status on Page 8.

Studies Opening a First Site in a New Country: Two hundred and eleven new study sites launched this week in countries where the sponsors did not have study sites. For more details, see Studies Opening a First Site in a New Country on Page 15.

Studies Opening Additional Sites in a Country: Five hundred and eighty-six new study sites launched this week in countries where the sponsors already had study sites. For more details, see Studies Opening Additional Sites in a Country on Page 24.

Study Sites by Country: A handy table that lists all countries with first-time and additional study sites that launched this week can be found at Study Sites by Country on Page 50.

Studies Under Planning: About 10% of the studies listed as in the planning stage are replaced each week. This week’s 301 listings include planned studies at Abbott, AstraZeneca, Baxter, Bayer, Biogen Idec, Bio-tronik, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Cytomedix, Daiichi Sankyo, GlaxoSmith-Kline, Hoffmann-La Roche, Janssen, Medtronic, Merck, Novartis, Novo Nordisk, Perle Bioscience, Pfizer, Sanofi, St. Jude, Takeda and Zimmer. For more details, see Studies Under Planning on Page 51.

Studies Ended or Halted: Fifteen studies were terminated, suspended or withdrawn this week, includ-ing studies sponsored by Amgen, Boehringer Ingelheim, Gilead, Janssen, Merck, Pfizer and St. Jude. For more details, see Studies Ended or Halted on Page 63.

ideNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe CoNdiTioN

NCT01947569 DIAVACS BIOLOGICAL 1. PLANNING 1 9012

YEARS 35

YEARS DIABETES

NCT01945021 OXONC DRUG 1. PLANNING 2 11018

YEARS N/A CRIZOTINIB

NCT01948024 BIORASI DRUG 2. RECRUITING 1 6618

YEARS 80

YEARS BIPOLAR DISORDER

NCT01945346 PROXIMAGEN DRUG 2. RECRUITING 2 7445

YEARS 75

YEARS OSTEOARTHRITIS, KNEE

NCT01949584 INSLEEP DEVICE 2. RECRUITING NA 3018

YEARS N/A

HABITUAL, SIMPLE SNORING

NCT01946581 MDBACKLINE PROCEDURE 2. RECRUITING NA 20018

YEARS 90

YEARS CATARACT

NCT01946178 MIRABILIS DEVICE 2. RECRUITING NA 8018

YEARS 55

YEARS UTERINE FIBROIDS

NCT01944670 SKELETAL DEVICE 2. RECRUITING NA 2521

YEARS N/A ELBOW DISLOCATION

NCT01948544 STRATIHEALTH 2. RECRUITING NA 3065

YEARS 85

YEARS COPD

Highlights, from Page 1

NeW SpoNSorS

This table lists new sponsors that have never previously registered studies at ClinicalTrials.gov.

1 Identifier: The official study ID given by ClinicalTrials.gov. 2 When the type field is empty, it is commonly a noninterventional study. 3 “NA” in the Phase field indicates that the sponsor has not provided any trial phase information; “NA” commonly represents a noninterventional study, but it can also represent an interventional device trial.

(Return to Page 1)

http://www.clinicaltrials.gov/ct2/show/NCT01947569









CliniCal Trial Magnifier WeeklySept. 26, 2013 page 3

(See New Studies, Page 4)


(Return to Page 1)

NeW STudieS

This table lists every new study registered in the past week.

ideNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N) miN aGe maX

aGe CoNdiTioN

NCT01949285 NEUROEN-ABLING

DEVICE 1. PLANNING 0 2421

YEARS 65

YEARS SPINAL CORD INJURY

NCT01945606 BAYER DRUG 1. PLANNING 1 1018

YEARS 75

YEARS HEART FAILURE

NCT01946789 ALTOR BIOLOGICAL 1. PLANNING 1 2018

YEARS N/A

ADVANCED MELANOMA

NCT01947153 BOEHRINGER INGELHEIM

DRUG 1. PLANNING 1 3618

YEARS 45

YEARS HEALTHY

NCT01947569 DIAVACS BIOLOGICAL 1. PLANNING 1 9012

YEARS 35

YEARS DIABETES

NCT01947777 INFINITY DRUG 1. PLANNING 1 1418

YEARS 50

YEARS HEALTHY

NCT01947920 JANSSEN DRUG 1. PLANNING 1 3018

YEARS 45

YEARS HEALTHY

NCT01947933 ELI LILLY BIOLOGICAL 1. PLANNING 1 4018

YEARS N/A PSORIASIS

NCT01948011 BIOPROJET DRUG 1. PLANNING 1 5218

YEARS 45

YEARS HEALTHY

NCT01948986 MERCK DRUG 1. PLANNING 1 4018

YEARS 80

YEARS DIABETES

NCT01949103 THERAVANCE DRUG 1. PLANNING 1 4818

YEARS 55

YEARS BACTERIAL INFECTIONS

NCT01949532 ONYX DRUG 1. PLANNING 1 3218

YEARS N/A

END-STAGE RENAL DISEASE

NCT01949545 ONYX DRUG 1. PLANNING 1 4018

YEARS N/A

HEPATIC IMPAIRMENT

NCT01945021 OXONC DRUG 1. PLANNING 2 11018



YEARS 65

YEARS DERMATITIS, ATOPIC

NCT01945281 MERCK DRUG 1. PLANNING 2 90 N/A 3

MONTHS CANDIDIASIS, INVASIVE

NCT01946477 CELGENE DRUG 1. PLANNING 2 8518

YEARS N/A MULTIPLE MYELOMA

NCT01946945 REPROGENET-ICS

GENETIC 1. PLANNING 2 24022

YEARS 42

YEARS PREGNANCY LOSS

NCT01947478 MEDTRONIC DEVICE 1. PLANNING 2 10020

YEARS 85

YEARS

POPLITEAL ARTERY OCCLUSION

NCT01948180 CELL MEDICA BIOLOGICAL 1. PLANNING 2 3018

YEARS N/A EBV

NCT01948219 PROTIP DEVICE 1. PLANNING 2 1518

YEARS N/A LARYNGECTOMY

NCT01948817 NOVARTIS DRUG 1. PLANNING 2 45 2 YEARS N/A TRANSFUSION DEPENDENT

























aGe CoNdiTioN

NCT01949051 GSK DRUG 1. PLANNING 2 7818

YEARS 65

YEARS RHINITIS

NCT01949090 GSK BIOLOGICAL 1. PLANNING 2 36065

YEARS N/A INFLUENZA

NCT01949324 NEUROTECH BIOLOGICAL 1. PLANNING 2 6821

YEARS 80

YEARS MACULAR TELANGIECTASIA

NCT01949441 CIRCASSIA BIOLOGICAL 1. PLANNING 2 4018

YEARS 65

YEARS RHINOCONJUNCTI-VITIS

NCT01944969 H LUNDBECK DRUG 1. PLANNING 3 1,18418

YEARS N/A

DEPRESSIVE DISORDER

NCT01945034 PFIZER DRUG 1. PLANNING 3 34012

YEARS N/A

SPRAINS AND STRAINS


YEARS N/A

HEPATITIS C, CHRONIC

NCT01945593 BAXTER BIOLOGICAL 1. PLANNING 3 250 N/A 75

YEARS HEMOPHILIA A

NCT01946204 ARAGON DRUG 1. PLANNING 3 1,20018

YEARS N/A

PROSTATIC NEOPLASMS

NCT01946412 VERTEX DRUG 1. PLANNING 3MISS-ING

2 YEARS N/A CYSTIC FIBROSIS

NCT01946620 MUNDIPHARMA DRUG 1. PLANNING 3 1,53040

YEARS N/A COPD

NCT01946711 PARI PHARMA DRUG 1. PLANNING 3 2018

YEARS N/A

CHRONIC POLYPOSIS

NCT01947491 PROMIUS DRUG 1. PLANNING 3 39618

YEARS N/A PSORIASIS



YEARS 74

YEARS DIABETES

NCT01947946 ASTRAZENECA BIOLOGICAL 1. PLANNING 3 84618

YEARS 75

YEARS ASTHMA

NCT01948193 SANOFI BIOLOGICAL 1. PLANNING 3 177 6 WEEKS 8 WEEKS INVASIVE HIB INFECTIONS

NCT01948830 NOVARTIS DRUG 1. PLANNING 3 64450

YEARS N/A

MACULAR DEGENERATION

NCT01948856 PIERRE FABRE DRUG 1. PLANNING 3 1,000 3 YEARS 4 YEARS URTI

NCT01949142 OTONOMY DRUG 1. PLANNING 3 2646

MONTHS 12

YEARS TYMPANOSTOMY TUBE PLACEMENT

NCT01949155 OTONOMY DRUG 1. PLANNING 3 2646

MONTHS 12

YEARS TYMPANOSTOMY TUBE PLACEMENT

NCT01949311 REGENERON DRUG 1. PLANNING 3 80018

YEARS N/A ATOPIC DERMATITIS

NCT01945489 ALLERGAN BIOLOGICAL 1. PLANNING 4 25818

YEARS N/A

OVERACTIVE BLADDER

NCT01947803 XIAN-JANSSEN DRUG 1. PLANNING 4 35318

YEARS 65

YEARS SCHIZOPHRENIA

NCT01947868 ASTRAZENECA 1. PLANNING 4 35620

YEARS N/A LUNG CANCER

New Studies, from Page 3

(See New Studies, Page 5)


(Return to Page 1)



























aGe CoNdiTioN


YEARS 85

YEARS ALZHEIMER’S DISEASE

NCT01949675 SANOFI BIOLOGICAL 1. PLANNING 4 336 1 YEAR N/A CHOLERA

NCT01945580 BOSTON SCIENTIFIC

PROCEDURE 1. PLANNING NA 45418

YEARS N/A

PELVIC ORGAN PROLAPSE

NCT01945762 ASTRAZENECA DRUG 1. PLANNING NA 8018

YEARS N/A THYROID CANCER

NCT01945970 UNILEVER OTHER 1. PLANNING NA 3040

YEARS 65

YEARS VASCULAR FUNCTION

NCT01946126 ALLERGAN 1. PLANNING NA 20018

YEARS 65

YEARS HEADACHE

NCT01947309 CELGENE DRUG 1. PLANNING NA 60018

YEARS N/A MULTIPLE MYELOMA

NCT01947829 B.BRAUN AVITUM

1. PLANNING NA 12018

YEARS N/A KIDNEY DISEASE

NCT01947894 PFIZER OTHER 1. PLANNING NA 90018

YEARS N/A

GROWTH HORMONE DEFICIENCY

NCT01948869 BAYER DEVICE 1. PLANNING NA 5518

YEARS 60


NCT01948882 BAYER DEVICE 1. PLANNING NA 59021

YEARS 44

YEARS CONTRACEPTION

NCT01949220 FRANCAIS 1. PLANNING NA 80 N/A N/A VON WILLEBRAND DISEASE

NCT01949415 CIRCASSIA 1. PLANNING NA 10516

YEARS 65



YEARS 65


NCT01944683 ACORDA OTHER 2. RECRUITING 1 2818

YEARS 75

YEARS HEART FAILURE

NCT01944735 CELTAXSYS DRUG 2. RECRUITING 1 3618

YEARS 55

YEARS CYSTIC FIBROSIS

NCT01945710 EISAI DRUG 2. RECRUITING 1 9618

YEARS N/A SOLID TUMORS

NCT01946074 ABBVIE DRUG 2. RECRUITING 1 7518

YEARS N/A

ADVANCED SOLID TUMORS

NCT01946386 LEO DRUG 2. RECRUITING 1 3518

YEARS 50

YEARS PSORIASIS VULGARIS

NCT01946568 DURATA DRUG 2. RECRUITING 1 363

MONTHS 11


NCT01946867 NANOBIOTIX DEVICE 2. RECRUITING 1 4865

YEARS N/A

HEAD AND NECK CANCER

NCT01948024 BIORASI DRUG 2. RECRUITING 1 6618

YEARS 80


NCT01944774 TAIGEN DRUG 2. RECRUITING 2 21018

YEARS 75

YEARS PNEUMONIA

NCT01945346 PROXIMAGEN DRUG 2. RECRUITING 2 7445

YEARS 75

YEARS OSTEOARTHRITIS, KNEE



(See New Studies, Page 6)(Return to Page 1)




























aGe CoNdiTioN

NCT01946841 LACTALIS DIETARY SUP.

2. RECRUITING 2 2018

YEARS N/A

NUTRITIONAL DISORDERS

NCT01947907 ASCENDIS DRUG 2. RECRUITING 2 52 3 YEARS 12

YEARS GROWTH HORMONE DEFICIENCY

NCT01948401 HOFFMANN-LA ROCHE

DRUG 2. RECRUITING 2 9712

YEARS 75

YEARS ASTHMA

NCT01944839 OPHTHOTECH DRUG 2. RECRUITING 3 62250

YEARS N/A


NCT01945684 DAEWOONG DRUG 2. RECRUITING 3MISS-ING

18 YEARS

N/A UPPER LIMB SPASTICITY

NCT01945775 BIOMARIN DRUG 2. RECRUITING 3 42918

YEARS N/A

BRCA 2 GENE MUTATION

NCT01945788 BIO SIDUS DRUG 2. RECRUITING 4 11050

YEARS 81

YEARS OSTEOPOROSIS

NCT01946243 AVID DRUG 2. RECRUITING 4 96 N/A N/A ALZHEIMERS DISEASE

NCT01946425 SANOFI BIOLOGICAL 2. RECRUITING 4 606

MONTHS 8 YEARS INFLUENZA

NCT01946438 SANOFI BIOLOGICAL 2. RECRUITING 4 20818

YEARS N/A INFLUENZA

NCT01944670 SKELETAL DEVICE 2. RECRUITING NA 2521

YEARS N/A

CHRONIC ELBOW DISLOCATION

NCT01944748 RAND BEHAVIORAL 2. RECRUITING NA 20012

YEARS 19

YEARS FAMILY FUNCTIONING

NCT01944917 AEROTEL 2. RECRUITING NA 4035

YEARS 75

YEARS MUSCULO- SKELETAL PAIN

NCT01945216 TAKEDA DRUG 2. RECRUITING NA 3,000 N/A N/A DIABETES

NCT01945424 SANOFI BIOLOGICAL 2. RECRUITING NA 50018

YEARS N/A INFLUENZA

NCT01946178 MIRABILIS DEVICE 2. RECRUITING NA 8018

YEARS 55


NCT01946581 MDBACKLINE PROCEDURE 2. RECRUITING NA 20018

YEARS 90

YEARS CATARACT

NCT01947816 ABBVIE 2. RECRUITING NA 1,500 N/A N/A ULCERATIVE COLITIS

NCT01947959 BAYER DRUG 2. RECRUITING NA 20,000 2 YEARS 89

YEARS PULMONARY EMBOLISM





NCT01948427 HYPERION 2. RECRUITING NA 500 N/A N/A UREA CYCLE DISORDER

NCT01948544 STRATIHEALTH 2. RECRUITING NA 3065

YEARS 85

YEARS COPD

NCT01949584 INSLEEP DEVICE 2. RECRUITING NA 3018

YEARS N/A



(See New Studies, Page 7)(Return to Page 1)



























aGe CoNdiTioN

NCT01948297 DEBIOPHARM DRUG 3. ONGOING 1 10618

YEARS N/A SOLID TUMOURS

NCT01945242 TAKEDA DRUG 3. ONGOING NA 1,000 N/A N/A DIABETES

NCT01945827 CODMAN & SHURTLEFF

DEVICE 3. ONGOING NA 15018

YEARS 80

YEARS INTRACRANIAL ANEURYSMS

NCT01947387 INTEGRA 3. ONGOING NA 40018

YEARS N/A

LOWER EXTREMITY WOUNDS

NCT01948258 SPD 3. ONGOING NA 39518

YEARS 45

YEARS PREGNANCY

NCT01947738 VIROBAY DRUG 4. COMPLETED 1 8918

YEARS 60

YEARS HEALTHY

NCT01949610 JOHNSON & JOHNSON

DRUG 4. COMPLETED 1 1018

YEARS 55

YEARS HEALTHY

NCT01948440 INFLEXXION BEHAVIORAL 4. COMPLETED 2 39 N/A N/A SUBSTANCE ABUSE

NCT01948531 DERMING DRUG 4. COMPLETED 4 3335

YEARS 65

YEARS WRINKLES

NCT01948583 DERMING DRUG 4. COMPLETED 4 28 N/A N/A MENOPAUSE

NCT01948570 DERMING 4. COMPLETED NA 4016

YEARS N/A ACNE

NCT01947608 NOVARTIS DRUG 7. OTHER NA MISS-ING

18 YEARS

N/A LUNG CANCER



NeW reSulTS

This table lists all industry-sponsored studies with results posted during the past week.


miN aGe

maX aGe CoNdiTioN

NCT01000376 EISAI DRUG 4. COMPLETED 1 1218

YEARS N/A CANCER

NCT01660815 AVID DRUG 4. COMPLETED 1 745

YEARS N/A

ALZHEIMER’S DISEASE

NCT00507689 GILEAD DRUG 4. COMPLETED 2 4018

YEARS 75

YEARS CHRONIC HEPATITIS B

NCT00619099 EISAI DRUG 4. COMPLETED 2 6718

YEARS N/A

MYELODYSPLASTIC SYNDROME

NCT01145560 ASTRAZENECA DRUG 4. COMPLETED 2 300 N/A N/A SEPTIC SHOCK


YEARS 75

YEARS DIABETES

NCT01334918 ASTELLAS DRUG 4. COMPLETED 2 12445

YEARS N/A

CORONARY ARTERY DISEASE

NCT01662882 AVID DRUG 4. COMPLETED 2 4850

YEARS N/A

COGNITIVE IMPAIRMENT

NCT00799825 GSK BIOLOGICAL 4. COMPLETED 3 34618

YEARS N/A

HUMAN PAPILLOMAVIRUS

NCT00838201 AMGEN DRUG 4. COMPLETED 3 38418

YEARS N/A TUMORS

(See New results, Page 8)(Return to Page 1)


























miN aGe

maX aGe CoNdiTioN



YEARS N/A

MELANOMA, NEOPLASMS

NCT01583777 SPECTRUM DRUG 2. RECRUITING 1 618

YEARS N/A CANCER

(See New Study Status, Page 9)

NeW STudy STaTuS

This table lists studies that reported updates in their status in the past week such as recruiting, ongoing or completed.


miN aGe

maX aGe CoNdiTioN

NCT00856635 TEVA DRUG 4. COMPLETED 3 4418

YEARS 45

YEARS OPTIC NEURITIS

NCT01210716 FENWAL DEVICE 4. COMPLETED 3 3718

YEARS N/A

ONCOLOGIC DISORDERS

NCT01216943 ALLERGAN DRUG 4. COMPLETED 3 12618

YEARS N/A

OCULAR HYPERTENSION

NCT01646398 PFIZER BIOLOGICAL 4. COMPLETED 3 76465

YEARS N/A

PNEUMOCOCCAL VACCINE

NCT00535145 ORTHO-MCNEIL DRUG 4. COMPLETED 4 12118

YEARS N/A

PSYCHOTIC DISORDERS

NCT01556451 MERCK BIOLOGICAL 4. COMPLETED 4 18050

YEARS N/A SHINGLES

NCT00739102 CORDIS DEVICE 4. COMPLETED NA 25030

YEARS N/A FEMORAL ARTERY

NCT01142661 EISAI DRUG 4. COMPLETED NA 918

YEARS N/A BREAST CANCER

NCT01181778 MERCK 4. COMPLETED NA 1,91918

YEARS 40

YEARS CONTRACEPTION

NCT01225926 ALCON DEVICE 4. COMPLETED NA 2421

YEARS N/A CATARACT

NCT01540370 ALLERGAN OTHER 4. COMPLETED NA 10218

YEARS N/A

OCULAR HYPERTENSION

NCT01568008 ALLERGAN DRUG 4. COMPLETED NA 93318

YEARS N/A

OCULAR HYPERTENSION

NCT01488877 PFIZER DRUG 7. TERMINATED 1 918

YEARS 65

YEARS DIABETIC NEPHROPATHY

NCT01627002 PROTAFFIN BIOLOGICAL 7. TERMINATED 1 4918

YEARS 65

YEARS HEALTHY VOLUNTEERS

NCT01214174 ICON DRUG 7. TERMINATED 2 4240

YEARS N/A

OCULAR INFLAMMATION

NCT01824602 BIAL PORTELA DRUG 7. TERMINATED 2 3818

YEARS N/A

BIPOLAR I DISORDER

NCT01011283 EISAI DRUG 7. TERMINATED 4 2618

YEARS N/A

MYELODYSPLASTIC SYNDROMES


YEARS N/A

OVERACTIVE BLADDER

New results, from Page 7

(Return to Page 1)























miN aGe

maX aGe CoNdiTioN

NCT01671904 GENENTECH DRUG 2. RECRUITING 1 7018

YEARS N/A

LYMPHOCYTIC LEUKEMIA, CHRONIC



YEARS N/A

LYMPHOMA, LEUKEMIA

NCT01691807 GSK DRUG 2. RECRUITING 1 70 18 YEARS N/A CANCER

NCT01810315 CONRAD DRUG 2. RECRUITING 1 4021

YEARS 89

YEARS HIV

NCT01830010 NOVARTIS DRUG 2. RECRUITING 1 1018

YEARS 65

YEARS HEMATOLOGICAL MALIGNANCIES

NCT01841463 PIRAMAL DRUG 2. RECRUITING 1 10018

YEARS N/A MELANOMA

NCT01854944 OTSUKA DRUG 2. RECRUITING 1 1218

YEARS 45

YEARS SCHIZOPHRENIA



NCT01925638 BAYER DRUG 2. RECRUITING 1 3018

YEARS 45

YEARS DRUG INTERACTIONS



YEARS N/A NEOPLASMS

NCT01943084 NOVO NORDISK DRUG 2. RECRUITING 1 3018

YEARS 40

YEARS HEALTHY



YEARS N/A


NCT01640158 POSIT BEHAV-IORAL

2. RECRUITING 2 13218

YEARS 40

YEARS BRAIN INJURY

NCT01717326 MERCK DRUG 2. RECRUITING 2 45018

YEARS N/A HEPATITIS C


YEARS 50

YEARS OPTIC NEURITIS

NCT01821118 PFIZER BIOLOGICAL 2. RECRUITING 2 3655

YEARS 80

YEARS CEREBRAL ANGIOPATHY

NCT01843062 ASTRAZENECA DRUG 2. RECRUITING 2 22818


NCT01844765 NOVARTIS DRUG 2. RECRUITING 2 70 1 YEAR 18

YEARS PROTEIN KINASE INHIBITOR

NCT01885195 NOVARTIS DRUG 2. RECRUITING 2 70 18 YEARS N/A MALIGNANCIES

NCT01886378 ULTRAGENYX DRUG 2. RECRUITING 2 20 6 YEARS 25

YEARS LCHAD DEFICIENCY

NCT01891305 VIAMET DRUG 2. RECRUITING 2 4818

YEARS 65

YEARS TINEA PEDIS

NCT01903265 TONIX DRUG 2. RECRUITING 2 12018

YEARS 65

YEARS PRIMARY FIBROMYALGIA

NCT01923753 ACTEGY DEVICE 2. RECRUITING 2 4316

YEARS N/A CYSTIC FIBROSIS

NCT01930461 STALLERGENES BIOLOGICAL 2. RECRUITING 2 48018

YEARS 50

YEARS MITE ALLERGY

New Study Status, from Page 8


(See New Study Status, Page 10)(Return to Page 1)



























miN aGe

maX aGe CoNdiTioN

NCT01941836 ESPERION DRUG 2. RECRUITING 2 32218

YEARS 80

YEARS HYPERCHOLESTER-OLEMIA

NCT01560637 UNITED THERAPEUTICS


YEARS 75

YEARS PULMONARY HYPERTENSION

NCT01623310 OPTINOSE DRUG 2. RECRUITING 3 200 18 YEARS N/A CHRONIC SINUSITIS

NCT01623323 OPTINOSE DRUG 2. RECRUITING 3 700 18 YEARS N/A CHRONIC SINUSITIS

NCT01846611 JANSSEN DRUG 2. RECRUITING 3 67018

YEARS N/A

FALLOPIAN TUBE NEOPLASMS

NCT01908426 EXELIXIS DRUG 2. RECRUITING 3 76018

YEARS N/A

HEPATOCELLULAR CARCINOMA


YEARS N/A VISUAL IMPAIRMENT



YEARS N/A



YEARS 80

YEARS DIABETES

NCT01917110 COOPERVISION DEVICE 2. RECRUITING 4 78 8 YEARS 12

YEARS MYOPIA

NCT01065103 INTERVENTION-AL CARDIOLOGY

PROCEDURE 2. RECRUITING NA 7019

YEARS N/A

MYOCARDIAL INFARCTION

NCT01755754 PARTNERSHIP FOR MICROBICIDES

DRUG 2. RECRUITING NA 16018

YEARS 45

YEARS CONDOM FUNCTIONALITY

NCT01869738 INSPIREMD DEVICE 2. RECRUITING NA 1,11418

YEARS N/A


NCT01899040 SCION DEVICE 2. RECRUITING NA 7618

YEARS 65

YEARS MIGRAINE

NCT01901289 COOK DEVICE 2. RECRUITING NA 20018

YEARS N/A

PERIPHERAL ARTERIAL DISEASE

NCT01902472 GILEAD 2. RECRUITING NA 15018

YEARS N/A HIV

NCT01906255 GILEAD 2. RECRUITING NA 7,00018

YEARS N/A HIV

NCT01916278 Q-MED DEVICE 2. RECRUITING NA MISS-ING

18 YEARS

65 YEARS

LIP FILLER INJECTIONS

NCT01943500 VIATAR 2. RECRUITING NA 5518

YEARS N/A

COLORECTAL CANCER

NCT01094288 MILLENNIUM DRUG 3. ONGOING 1 4018

YEARS N/A

ADENOCARCINOMA PROSTATE


DRUG 3. ONGOING 1 14018

YEARS N/A NEOPLASMS

NCT01390337 AMBIT DRUG 3. ONGOING 1 5818

YEARS 60

YEARS LEUKEMIA, MYELOID, ACUTE

NCT01468467 AMBIT DRUG 3. ONGOING 1 3018

YEARS N/A

LEUKEMIA, MYELOID, ACUTE

NCT01530022 UCB DRUG 3. ONGOING 1 5018

YEARS 55

YEARS HEALTHY


(See New Study Status, Page 11)


(Return to Page 1)



























miN aGe

maX aGe CoNdiTioN

NCT01560377 NOVADAQ DEVICE 3. ONGOING 1 15018

YEARS N/A DIVERTICULITIS

NCT01596647 NOVARTIS DRUG 3. ONGOING 1 3818


NCT01673178 PFIZER OTHER 3. ONGOING 1 10030

YEARS 70

YEARS DIABETES



YEARS 65

YEARS DIABETES

NCT01768663 VERTEX DRUG 3. ONGOING 1 7818

YEARS 55


NCT01769417 MEDIMMUNE DRUG 3. ONGOING 1 3318

YEARS 65

YEARS STAPHYLOCOCCUS AUREUS

NCT01780246 ISIS DRUG 3. ONGOING 1 28 2 YEARS 15

YEARS SPINAL MUSCULAR ATROPHY



YEARS 55

YEARS HEALTHY

NCT01847391 GILEAD DRUG 3. ONGOING 1 3618

YEARS 65

YEARS ISCHEMIC HEART DISEASE

NCT01855945 NOVARTIS BIOLOGICAL 3. ONGOING 1 600 3 YEARS 65

YEARS INFLUENZA

NCT00494234 ASTRAZENECA DRUG 3. ONGOING 2 54 18 YEARS N/A BREAST CANCER

NCT00494442 ASTRAZENECA DRUG 3. ONGOING 2 5718

YEARS N/A

OVARIAN NEOPLASM

NCT01069809 ARGOS BIOLOGICAL 3. ONGOING 2 4218

YEARS 60

YEARS HIV




NCT01304524 INOVIO BIOLOGICAL 3. ONGOING 2 14818

YEARS 55

YEARS CERVICAL NEOPLASIA

NCT01496742 GENENTECH DRUG 3. ONGOING 2 25918


NCT01602120 GENENTECH DRUG 3. ONGOING 2 9060

YEARS 89

YEARS GEOGRAPHIC ATROPHY



YEARS N/A DIABETES

NCT01732198 NURON BIOLOGICAL 3. ONGOING 2 22012

MONTHS 15

MONTHS INFECTIOUS DISEASE

NCT01885104 MERCK DRUG 3. ONGOING 2 7218

YEARS 75

YEARS CONSTIPATION

NCT01934036 CATALYSIS DIETARY SUP.

3. ONGOING 2 9235

YEARS 60

YEARS OVERWEIGHT

NCT00585312 PFIZER DRUG 3. ONGOING 3 20010

YEARS 17

YEARS ADENOMATOUS POLYPOSIS COLI

NCT01072981 NEWLINK GENETICS

BIOLOGICAL 3. ONGOING 3 72218

YEARS N/A

PANCREATIC CANCER

NCT01154140 PFIZER DRUG 3. ONGOING 3 33418































miN aGe

maX aGe CoNdiTioN

NCT01222884 PHARMACOS-MOS


YEARS N/A

CHRONIC KIDNEY DISEASE




NCT01396421 OTSUKA DRUG 3. ONGOING 3 63018

YEARS 65

YEARS SCHIZOPHRENIA

NCT01445678 CUBIST DRUG 3. ONGOING 3 50018

YEARS N/A

INTRA-ABDOMINAL INFECTION

NCT01455194 TAKEDA DRUG 3. ONGOING 3 45012

YEARS 70

YEARS BRONCHIAL ASTHMA

NCT01464905 NURON BIOLOGICAL 3. ONGOING 3 50018

YEARS 60

YEARS MULTIPLE SCLEROSIS

NCT01480245 GSK DRUG 3. ONGOING 3 220 5 YEARS N/A MUSCULAR DYSTROPHIES

NCT01480713 IRSICAIXA DRUG 3. ONGOING 3 4118

YEARS 65

YEARS HIV



YEARS N/A

RHEUMATOID ARTHRITIS

NCT01678820 MERCK DRUG 3. ONGOING 3 75018

YEARS 79

YEARS DIABETES

NCT01854528 ABBVIE DRUG 3. ONGOING 3 15018

YEARS 65

YEARS CHRONIC HEPATITIS C

NCT01375465 EUROCOR DEVICE 3. ONGOING 4 5018

YEARS N/A CORONARY ARTERY

NCT01453374 ALKERMES DRUG 3. ONGOING 4 3018

YEARS N/A

OPIOID DEPENDENCE

NCT00209274 EVALVE DEVICE 3. ONGOING NA 1,31718

YEARS N/A

MITRAL INSUFFICIENCY

NCT00949676 MEDTRONIC 3. ONGOING NA 6018

YEARS N/A

SYSTOLIC HEART FAILURE

NCT01415154 NEURONETICS DEVICE 3. ONGOING NA 5018

YEARS 70

YEARS DEPRESSIVE DISORDER

NCT01444456 AMGEN 3. ONGOING NA 1,264 18 YEARS N/A GASTRIC CANCER

NCT01534650 GREAT LAKES 3. ONGOING NA 10018

YEARS N/A ESSENTIAL TREMOR

NCT01556711 BRAINSCOPE 3. ONGOING NA 75018

YEARS 80

YEARS CRANIOCEREBRAL TRAUMA

NCT01585142 NESTLE OTHER 3. ONGOING NA 80 N/A 14 DAYS DIETARY MODIFICATION

NCT01604122 PFIZER OTHER 3. ONGOING NA 50018

YEARS 85

YEARS AMYLOIDOSIS

NCT01613287 MILTENYI DEVICE 3. ONGOING NA 1218

YEARS 80


NCT01635049 AUXOGYN 3. ONGOING NA 100 N/A 43

YEARS INFERTILITY

NCT01690533 BAYER DRUG 3. ONGOING NA 49720

YEARS N/A

ANTI-INFECTIVE AGENTS






























miN aGe

maX aGe CoNdiTioN

NCT01699529 MEDTRONIC DEVICE 3. ONGOING NA 5018

YEARS 80

YEARS HYPERTENSION

NCT00315731 GSK BIOLOGICAL 4. COMPLETED 1 1518

YEARS N/A

LYMPHOMA, FOLLICULAR

NCT00316940 ONCOTHERA-PEUTICS


YEARS N/A

MYELOMA AND PLASMA CELL

NCT00596648 EXELIXIS DRUG 4. COMPLETED 1 9218

YEARS N/A CARCINOMA, LUNG

NCT00642954 MERCK DRUG 4. COMPLETED 1 2818

YEARS N/A MYELOMA

NCT00823355 MUNDIPHARMA DRUG 4. COMPLETED 1 2420

YEARS N/A

T/NK-CELL MALIGNANCIES

NCT01100619 EXELIXIS DRUG 4. COMPLETED 1 4018

YEARS N/A

RENAL CELL CARCINOMA

NCT01405963 AMGEN DRUG 4. COMPLETED 1 3118

YEARS 60

YEARS ASTHMA



YEARS 50

YEARS HEALTHY



YEARS 65

YEARS DIABETES

NCT01803373 JANSSEN DRUG 4. COMPLETED 1 3618

YEARS 55

YEARS BIOLOGICAL AVAILABILITY

NCT01866033 JANSSEN DRUG 4. COMPLETED 1 818

YEARS 55

YEARS HEALTHY

NCT01873339 GSK DRUG 4. COMPLETED 1 2618

YEARS 65

YEARS ATHEROSCLEROSIS

NCT01887626 ASTRAZENECA DRUG 4. COMPLETED 1 3618

YEARS 50

YEARS HEATHY

NCT01897493 ELI LILLY DRUG 4. COMPLETED 1 2018

YEARS 65

YEARS HEALTHY

NCT01911637 VIROBAY DRUG 4. COMPLETED 1 4818

YEARS 60

YEARS HEALTHY

NCT01919385 ANIMAS DEVICE 4. COMPLETED 1 1221

YEARS 65

YEARS DIABETES

NCT00269152 ELI LILLY DRUG 4. COMPLETED 2 12218


NCT01035502 CLAVIS DRUG 4. COMPLETED 2 5118

YEARS N/A LEUKEMIA

NCT01038804 ASTELLAS DRUG 4. COMPLETED 2 10118


NCT01145560 ASTRAZENECA DRUG 4. COMPLETED 2 300 N/A N/A SEPTIC SHOCK


YEARS N/A


NCT01592786 FOREST DRUG 4. COMPLETED 2 906 6 YEARS 12

YEARS PERVASIVE DISORDER


YEARS N/A RHINITIS, ALLERGIC






























miN aGe

maX aGe CoNdiTioN

NCT01768975 OLATEC DRUG 4. COMPLETED 2 7935

YEARS 80

YEARS OSTEOARTHRITIS

NCT00104611 NEURONETICS DEVICE 4. COMPLETED 3 28618

YEARS 70


NCT01120340 SOFAR DRUG 4. COMPLETED 3 10518

YEARS N/A

DIVERTICULAR DISEASE

NCT01147939 CLAVIS DRUG 4. COMPLETED 3 38118

YEARS N/A LEUKEMIA


YEARS 17

YEARS BIPOLAR DISORDER, PEDIATRIC


YEARS N/A CROHN’S DISEASE


DRUG 4. COMPLETED 3 1,40618

YEARS N/A DIABETES


DRUG 4. COMPLETED 3 2,62440

YEARS N/A COPD

NCT01445665 CUBIST DRUG 4. COMPLETED 3 50018

YEARS N/A

INTRA-ABDOMINAL INFECTION

NCT01510912 IROKO DRUG 4. COMPLETED 3 60040

YEARS N/A OSTEOARTHRITIS


DRUG 4. COMPLETED 3 6 9 YEARS 18

YEARS

JUVENILE IDIOPATHIC ARTHRITIS



YEARS N/A DIABETES

NCT01718483 SHIRE DRUG 4. COMPLETED 3 38318

YEARS 55

YEARS BINGE EATING DISORDER

NCT01718509 SHIRE DRUG 4. COMPLETED 3 39018

YEARS 55

YEARS BINGE EATING DISORDER

NCT01727700 OTSUKA DRUG 4. COMPLETED 3 133 7 YEARS 17

YEARS TIC DISORDER

NCT01735175 SANDOZ DRUG 4. COMPLETED 3 31818




YEARS N/A DIABETES

NCT01880697 NOVARTIS BIOLOGICAL 4. COMPLETED 3 12618

YEARS N/A INFLUENZA

NCT01885117 NOVARTIS BIOLOGICAL 4. COMPLETED 3 12518

YEARS N/A INFLUENZA

NCT01370356 PFIZER DRUG 4. COMPLETED 4 1,49418

YEARS N/A

SMOKING CESSATION

NCT01586338 SANOFI DRUG 4. COMPLETED 4 23730

YEARS N/A OSTEOARTHRITIS


YEARS N/A COPD

NCT00739102 CORDIS DEVICE 4. COMPLETED NA 25030

YEARS N/A

FEMORAL ARTERY DISEASE




























ideNTifier1 CouNTry SpoNSor Type2 STaTuS pHaSe3 SiZe (N)

miN aGe

maX aGe CoNdiTioN

NCT01885208 ARGENTINA NOVO NORDISK


YEARS N/A DIABETES

NCT01930188 ARGENTINA NOVO NORDISK

DRUG 1. PLANNING 3 1,20018

YEARS N/A DIABETES

NCT01945788 ARGENTINA BIO SIDUS DRUG 2. RECRUITING 4 11050

YEARS 81

YEARS OSTEOPOROSIS

NCT01928459 AUSTRALIA NOVARTIS DRUG 1. PLANNING 1 5518


NCT01949324 AUSTRALIA NEUROTECH BIOLOGICAL 1. PLANNING 2 6821

YEARS 80

YEARS MACULAR TEL-ANGIECTASIA

NCT01949311 AUSTRALIA REGENERON DRUG 1. PLANNING 3 80018

YEARS N/A

ATOPIC DERMATITIS

NCT01857193 AUSTRALIA NOVARTIS DRUG 2. RECRUITING 1 18518

YEARS N/A

BREASTCANCER

NCT01928459 BELGIUM NOVARTIS DRUG 1. PLANNING 1 5518


NCT01948219 BELGIUM PROTIP DEVICE 1. PLANNING 2 1518

YEARS N/A

TOTAL LARYNGECTOMY

NCT01945762 BELGIUM ASTRAZENECA DRUG 1. PLANNING NA 8018

YEARS N/A

THYROID CANCER

NCT01857193 BELGIUM NOVARTIS DRUG 2. RECRUITING 1 18518

YEARS N/A

BREAST CANCER

NCT01480479 BELGIUM CELLDEX DRUG 2. RECRUITING 3 44018

YEARS N/A GLIOMA

NCT01708174 BELGIUM NOVARTIS DRUG 2. RECRUITING 3 109 N/A N/A MEDULLOBLAS-TOMA

STudieS opeNiNG a firST SiTe iN a NeW CouNTry

This table lists studies that launched a site in a country for the first time in the past week.


(See Studies opening a first Site in a New Country, Page 16)(Return to Page 1)


miN aGe

maX aGe CoNdiTioN

NCT00795873 ELA 4. COMPLETED NA 2,260 18 YEARS N/A HEART FAILURE

NCT01087957 INNOVATIVE NEURO.

DEVICE 4. COMPLETED NA 49618

YEARS N/A STROKE


4. COMPLETED NA 57115

YEARS N/A

RESTLESS LEGS SYNDROME

NCT01577147 SPD OTHER 4. COMPLETED NA 60018

YEARS 45

YEARS PREGNANCY

NCT01614496 PARC TAULI OTHER 4. COMPLETED NA MISS-ING

18 YEARS

65 YEARS

DIABETES



YEARS N/A

COLORECTAL CANCER

NCT01779895 NESTLE DIETARY SUP.


YEARS 65

YEARS RHINITIS, ALLERGIC

NCT01790256 CEREVE DEVICE 4. COMPLETED NA 144 22 YEARS N/A PRIMARY INSOMNIA

NCT01803022 LEO 4. COMPLETED NA 41918

YEARS N/A

VENOUS THROMBOEMBOLISM


























miN aGe

maX aGe CoNdiTioN

NCT01839526 BELGIUM GENZYME DRUG 2. RECRUITING NA 100 5 YEARS 25

YEARS FABRY DISEASE

NCT01869738 BELGIUM INSPIREMD DEVICE 2. RECRUITING NA 1,11418

YEARS N/A


NCT01911897 BELGIUM VASCULAR DYNAMICS

DEVICE 2. RECRUITING NA 2018

YEARS 80

YEARS HYPERTENSION

NCT01948817 BRAZIL NOVARTIS DRUG 1. PLANNING 2 45 2 YEARS N/A TRANSFUSION DEPENDENT

NCT01489111 BULGARIA NOVO NORDISK


YEARS N/A HAEMOPHILIA A

NCT01928459 CANADA NOVARTIS DRUG 1. PLANNING 1 5518


NCT01947933 CANADA ELI LILLY BIOLOGICAL 1. PLANNING 1 4018

YEARS N/A PSORIASIS

NCT01907100 CANADA BOEHRINGER INGELHEIM


YEARS N/A MESOTHELIOMA

NCT01949441 CANADA CIRCASSIA BIOLOGICAL 1. PLANNING 2 4018

YEARS 65

YEARS RHINOCON-JUNCTIVITIS

NCT01949311 CANADA REGENERON DRUG 1. PLANNING 3 80018

YEARS N/A

ATOPIC DERMATITIS

NCT01949415 CANADA CIRCASSIA 1. PLANNING NA 10516

YEARS 65


NCT01949428 CANADA CIRCASSIA 1. PLANNING NA 10018

YEARS 65


NCT01831427 CANADA GILEAD DRUG 2. RECRUITING 1 7418

YEARS 65

YEARS ULCERATIVE COLITIS

NCT01786668 CANADA PFIZER DRUG 2. RECRUITING 2 20018

YEARS N/A

ANKYLOSING SPONDYLITIS

NCT01843374 CANADA MEDIMMUNE DRUG 2. RECRUITING 2 18018


NCT01828112 CANADA NOVARTIS DRUG 2. RECRUITING 3 23618


NCT01841684 CANADA MERCK DRUG 2. RECRUITING 3 4518

YEARS N/A

HYPERCHOLES-TEROLEMIA

NCT01697358 CANADA MEDTRONIC DEVICE 2. RECRUITING 4 30018

YEARS N/A

PAIN IN LEG, UNSPECIFIED


DRUG 2. RECRUITING 4 8,30018

YEARS N/A DIABETES

NCT01656395 CHILE MERCK DRUG 2. RECRUITING 2 1,47518

YEARS 65

YEARS ASTHMA

NCT01945021 CHINA OXONC DRUG 1. PLANNING 2 11018


NCT01947309 CHINA CELGENE DRUG 1. PLANNING NA 60018

YEARS N/A

MULTIPLE MYELOMA

NCT01947829 CHINA B.BRAUN AVITUM


YEARS N/A

KIDNEY DISEASE

NCT01944774 CHINA TAIGEN DRUG 2. RECRUITING 2 21018

YEARS 75

YEARS PNEUMONIA


(See Studies opening a first Site in a New Country, Page 17)

Studies opening a first Site in a New Country, from Page 15

(Return to Page 1)



























miN aGe

maX aGe CoNdiTioN

NCT01656395 COLOMBIA MERCK DRUG 2. RECRUITING 2 1,47518

YEARS 65

YEARS ASTHMA

NCT01201356 COSTA RICA NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01949311 CZECH REP REGENERON DRUG 1. PLANNING 3 80018

YEARS N/A

ATOPIC DERMATITIS

NCT01762852 CZECH REP GSK DRUG 2. RECRUITING 2 9418

YEARS 75

YEARS GLOMERULO-NEPHRITIS

NCT01767467 CZECH REP GSK BIOLOGICAL 2. RECRUITING 3 50218

YEARS N/A

HERPES ZOSTER

NCT01574703 DENMARK PFIZER DRUG 2. RECRUITING 4 8,00018

YEARS 75

YEARS SMOKING CESSATION

NCT01703208 FINLAND MERCK DRUG 2. RECRUITING 3 4,00040

YEARS N/A DIABETES

NCT01928459 FRANCE NOVARTIS DRUG 1. PLANNING 1 5518


NCT01948011 FRANCE BIOPROJET DRUG 1. PLANNING 1 5218

YEARS 45

YEARS HEALTHY

NCT01949311 FRANCE REGENERON DRUG 1. PLANNING 3 80018

YEARS N/A

ATOPICDERMATITIS

NCT01945762 FRANCE ASTRAZENECA DRUG 1. PLANNING NA 8018

YEARS N/A

THYROID CANCER

NCT01946386 FRANCE LEO DRUG 2. RECRUITING 1 3518

YEARS 50

YEARS PSORIASIS VULGARIS

NCT01946867 FRANCE NANOBIOTIX DEVICE 2. RECRUITING 1 4865

YEARS N/A

HEAD AND NECK CANCER

NCT01717326 FRANCE MERCK DRUG 2. RECRUITING 2 45018

YEARS N/A HEPATITIS C

NCT01946841 FRANCE LACTALIS DIETARY SUP. 2. RECRUITING 2 2018

YEARS N/A

NUTRITIONAL DISORDERS

NCT01479244 FRANCE GALENA BIOLOGICAL 2. RECRUITING 3 70018

YEARS N/A

BREAST CANCER

NCT01566695 FRANCE CELGENE DRUG 2. RECRUITING 3 38618

YEARS N/A LEUKEMIA

NCT01928459 GERMANY NOVARTIS DRUG 1. PLANNING 1 5518


NCT01840410 GERMANY NOVARTIS DRUG 1. PLANNING 3 18712

YEARS N/A


NCT01895777 GERMANY BOEHRINGER INGELHEIM

DRUG 1. PLANNING 3 270 N/A 17

YEARS THROMBOEM-BOLISM

NCT01946711 GERMANY PARI PHARMA DRUG 1. PLANNING 3 2018

YEARS N/A

CHRONIC POLYPOSIS

NCT01949311 GERMANY REGENERON DRUG 1. PLANNING 3 80018

YEARS N/A

ATOPIC DERMATITIS

NCT01945762 GERMANY ASTRAZENECA DRUG 1. PLANNING NA 8018

YEARS N/A

THYROID CANCER

NCT01949220 GERMANY FRANCAIS 1. PLANNING NA 80 N/A N/A VON WILLEBRAND DISEASE




(Return to Page 1)



























miN aGe

maX aGe CoNdiTioN

NCT01857193 GERMANY NOVARTIS DRUG 2. RECRUITING 1 18518

YEARS N/A

BREAST CANCER

NCT01947907 GERMANY ASCENDIS DRUG 2. RECRUITING 2 52 3 YEARS 12

YEARS


NCT01479244 GERMANY GALENA BIOLOGICAL 2. RECRUITING 3 70018

YEARS N/A

BREAST CANCER

NCT01947959 GERMANY BAYER DRUG 2. RECRUITING NA 20,000 2 YEARS 89


NCT01840410 GREECE NOVARTIS DRUG 1. PLANNING 3 18712

YEARS N/A


NCT01628393 GREECE RECEPTOS DRUG 2. RECRUITING 2 21018

YEARS 55


NCT01930188 HONG KONG NOVO NORDISK


YEARS N/A DIABETES

NCT01857193 HONG KONG NOVARTIS DRUG 2. RECRUITING 1 18518

YEARS N/A

BREAST CANCER

NCT01949311 HUNGARY REGENERON DRUG 1. PLANNING 3 80018

YEARS N/A

ATOPIC DERMATITIS

NCT01628393 HUNGARY RECEPTOS DRUG 2. RECRUITING 2 21018

YEARS 55


NCT01947907 HUNGARY ASCENDIS DRUG 2. RECRUITING 2 52 3 YEARS 12

YEARS


NCT01948193 INDIA SANOFI BIOLOGICAL 1. PLANNING 3 177 6 WEEKS 8 WEEKS HIB INFECTIONS

NCT01393626 INDIA PFIZER DRUG 2. RECRUITING 2 27518

YEARS 75

YEARS CROHN’S DISEASE

NCT01734785 INDIA BOEHRINGER INGELHEIM


YEARS N/A DIABETES

NCT01922102 INDIA NOVARTIS DRUG 2. RECRUITING 3 47518

YEARS N/A

VISUAL IMPAIRMENT

NCT01835431 ISRAEL NOVO NORDISK

DRUG 1. PLANNING 3 346 1 YEAR 17

YEARS DIABETES

NCT00625378 ISRAEL BAYER DRUG 2. RECRUITING 3 1,000 16 YEARS N/A NEOPLASMS

NCT01944917 ISRAEL AEROTEL 2. RECRUITING NA 4035

YEARS 75

YEARS MUSCULO-SKELETAL PAIN

NCT01928459 ITALY NOVARTIS DRUG 1. PLANNING 1 5518


NCT01885208 ITALY NOVO NORDISK


YEARS N/A DIABETES

NCT01948856 ITALY PIERRE FABRE DRUG 1. PLANNING 3 1,000 3 YEARS 4 YEARS URTI

NCT01945762 ITALY ASTRAZENECA DRUG 1. PLANNING NA 8018

YEARS N/A

THYROID CANCER

NCT01945970 ITALY UNILEVER OTHER 1. PLANNING NA 3040

YEARS 65

YEARS VASCULAR FUNCTION

NCT01949220 ITALY FRANCAIS 1. PLANNING NA 80 N/A N/A VON WILLEBRAND DISEASE




(Return to Page 1)



























miN aGe

maX aGe CoNdiTioN

NCT01665391 ITALY GENZYME DRUG 2. RECRUITING 2 8818

YEARS N/A

GLOMERULO-SCLEROSIS

NCT01671007 ITALY BOEHRINGER INGELHEIM

2. RECRUITING NA 18,09118

YEARS N/A

ATRIAL FIBRILLATION

NCT01945021 JAPAN OXONC DRUG 1. PLANNING 2 11018


NCT01945086 JAPAN JANSSEN DRUG 1. PLANNING 2 7220

YEARS 65


NCT01947478 JAPAN MEDTRONIC DEVICE 1. PLANNING 2 10020

YEARS 85

YEARS

POPLITEAL ARTERY OCCLUSION

NCT01947855 JAPAN BOEHRINGER INGELHEIM


YEARS 74

YEARS DIABETES

NCT01949311 JAPAN REGENERON DRUG 1. PLANNING 3 80018

YEARS N/A

ATOPIC DERMATITIS

NCT01945216 JAPAN TAKEDA DRUG 2. RECRUITING NA 3,000 N/A N/A DIABETES

NCT01947816 JAPAN ABBVIE 2. RECRUITING NA 1,500 N/A N/A ULCERATIVE COLITIS

NCT01928459 KOREA, SOUTH NOVARTIS DRUG 1. PLANNING 1 5518


NCT01945021 KOREA, SOUTH OXONC DRUG 1. PLANNING 2 11018


NCT01740336 KOREA, SOUTH GENENTECH DRUG 2. RECRUITING 2 18018

YEARS N/A

BREAST CANCER

NCT01945684 KOREA, SOUTH DAEWOONG DRUG 2. RECRUITING 3MISS-ING

18 YEARS

N/A LIMB SPASTICITY

NCT01946620 LATVIA MUNDIPHARMA DRUG 1. PLANNING 3 1,53040

YEARS N/A COPD

NCT01948817 LEBANON NOVARTIS DRUG 1. PLANNING 2 45 2 YEARS N/A TRANSFUSION DEPENDENT

NCT01895777 LITHUANIA BOEHRINGER INGELHEIM


YEARS THROMBOEM-BOLISM

NCT01948856 LITHUANIA PIERRE FABRE DRUG 1. PLANNING 3 1,000 3 YEARS 4 YEARS URTI

NCT01560624 MEXICO UNITED THERAPEUTICS


YEARS 75


NCT01560637 MEXICO UNITED THERAPEUTICS


YEARS 75


NCT01566695 MEXICO CELGENE DRUG 2. RECRUITING 3 386 18 YEARS N/A LEUKEMIA

NCT01682512 MEXICO BOEHRINGER INGELHEIM


YEARS 80

YEARS ARTHRITIS, RHEUMATOID

NCT00867815 MEXICO BAYER DRUG 2. RECRUITING 4 28440

YEARS N/A

OPTIC NEUROPATHY

NCT01574703 MEXICO PFIZER DRUG 2. RECRUITING 4 8,00018

YEARS 75


NCT01946178 MEXICO MIRABILIS DEVICE 2. RECRUITING NA 8018

YEARS 55


NCT01945606 NETHERLANDS BAYER DRUG 1. PLANNING 1 1018

YEARS 75

YEARS HEART FAILURE




(Return to Page 1)




























miN aGe

maX aGe CoNdiTioN

NCT01945762 NETHERLANDS ASTRAZENECA DRUG 1. PLANNING NA 8018

YEARS N/A

THYROID CANCER

NCT01905657 NETHERLANDS MERCK BIOLOGICAL 2. RECRUITING 2 92018


NCT01598844 NETHERLANDS JENAVALVE DEVICE 2. RECRUITING NA 180 N/A N/A AORTIC STENOSIS

NCT01947985 NETHERLANDS BAYER DRUG 2. RECRUITING NA 20,000 2 YEARS 89


NCT01949311 NEW ZEALAND REGENERON DRUG 1. PLANNING 3 80018

YEARS N/A

ATOPIC DERMATITIS

NCT01682512 NORWAY BOEHRINGER INGELHEIM


YEARS 80


NCT01839526 NORWAY GENZYME DRUG 2. RECRUITING NA 100 5 YEARS 25

YEARS FABRY DISEASE

NCT01949675 PHILIPPINES SANOFI BIOLOGICAL 1. PLANNING 4 336 1 YEAR N/A CHOLERA

NCT01703208 PHILIPPINES MERCK DRUG 2. RECRUITING 3 4,00040

YEARS N/A DIABETES

NCT01949311 POLAND REGENERON DRUG 1. PLANNING 3 80018

YEARS N/A

ATOPIC DERMATITIS

NCT01751776 POLAND BOEHRINGER INGELHEIM


YEARS 70

YEARS HEALTHY

NCT01566695 POLAND CELGENE DRUG 2. RECRUITING 3 38618

YEARS N/A LEUKEMIA

NCT01828099 POLAND NOVARTIS DRUG 2. RECRUITING 3 34818


NCT01511913 POLAND BMS 2. RECRUITING NA 1,80018

YEARS N/A MELANOMA

NCT01731600 PORTUGAL NOVO NORDISK

DRUG 2. RECRUITING 3 60 N/A 11

YEARS HAEMOPHILIA A

NCT01767090 ROMANIA ASTELLAS DRUG 2. RECRUITING 2 60018

YEARS 45

YEARS ENDOMETRIOSIS

NCT01682759 ROMANIA MERCK DRUG 2. RECRUITING 3 68018

YEARS N/A DIABETES

NCT01947153 RUSSIA BOEHRINGER INGELHEIM


YEARS 45

YEARS HEALTHY

NCT01628393 RUSSIA RECEPTOS DRUG 2. RECRUITING 2 21018

YEARS 55


NCT01947907 RUSSIA ASCENDIS DRUG 2. RECRUITING 2 52 3 YEARS 12

YEARS


NCT01828099 RUSSIA NOVARTIS DRUG 2. RECRUITING 3 34818


NCT01828112 RUSSIA NOVARTIS DRUG 2. RECRUITING 3 23618


NCT01928459 SINGAPORE NOVARTIS DRUG 1. PLANNING 1 5518


NCT01840410 SINGAPORE NOVARTIS DRUG 1. PLANNING 3 18712

YEARS N/A





(Return to Page 1)



























miN aGe

maX aGe CoNdiTioN

NCT01697579 SOUTH AFRICA MERCK DRUG 2. RECRUITING 2 256 N/A 17

YEARS

CHEMOTHERAPY NAUSEA/ VOMITING

NCT00625378 SOUTH AFRICA BAYER DRUG 2. RECRUITING 3 1,00016

YEARS N/A NEOPLASMS

NCT01814748 SOUTH AFRICA MERCK DRUG 2. RECRUITING 3 20018

YEARS 44

YEARS DIABETES

NCT01928459 SPAIN NOVARTIS DRUG 1. PLANNING 1 5518



YEARS N/A


NCT01945762 SPAIN ASTRAZENECA DRUG 1. PLANNING NA 8018

YEARS N/A

THYROID CANCER

NCT01295827 SPAIN MERCK DRUG 2. RECRUITING 1 1,06718

YEARS N/A

CANCER, SOLID TUMOR

NCT01562275 SPAIN GENENTECH DRUG 2. RECRUITING 1 10818

YEARS N/A NEOPLASMS

NCT01857193 SPAIN NOVARTIS DRUG 2. RECRUITING 1 18518

YEARS N/A

BREAST CANCER

NCT01628393 SPAIN RECEPTOS DRUG 2. RECRUITING 2 21018

YEARS 55


NCT01917110 SPAIN COOPERVISION DEVICE 2. RECRUITING 4 78 8 YEARS 12

YEARS MYOPIA

NCT01839526 SPAIN GENZYME DRUG 2. RECRUITING NA 100 5 YEARS 25

YEARS FABRY DISEASE

NCT01791361 SWEDEN AMGEN OTHER 2. RECRUITING NA 45018

YEARS N/A

COLORECTAL CANCER

NCT01916278 SWEDEN Q-MED DEVICE 2. RECRUITING NA MISS-ING

18 YEARS

65 YEARS


NCT01928459 SWITZERLAND NOVARTIS DRUG 1. PLANNING 1 5518


NCT01846611 SWITZERLAND JANSSEN DRUG 2. RECRUITING 3 67018

YEARS N/A


NCT01945021 TAIWAN OXONC DRUG 1. PLANNING 2 11018


NCT01947868 TAIWAN ASTRAZENECA 1. PLANNING 4 35620


NCT01944774 TAIWAN TAIGEN DRUG 2. RECRUITING 2 21018

YEARS 75

YEARS PNEUMONIA

NCT01098110 TAIWAN MERCK DRUG 2. RECRUITING 3 52820

YEARS 64

YEARS SCHIZOPHRENIA

NCT01757405 TAIWAN BAXTER BIOLOGICAL 2. RECRUITING 3 3412

YEARS 65

YEARS HEMOPHILIA B

NCT01948817 THAILAND NOVARTIS DRUG 1. PLANNING 2 45 2 YEARS N/A TRANSFUSION DEPENDENT

NCT01838044 THAILAND PFIZER DRUG 1. PLANNING 4 36618

YEARS 75

YEARS BACK PAIN




(Return to Page 1)


























miN aGe

maX aGe CoNdiTioN

NCT01641926 THAILAND MERCK BIOLOGICAL 2. RECRUITING 3 1,40018

YEARS N/A

HEPATITIS B, CHRONIC

NCT01663402 THAILAND SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A

ACUTE CORONARY SYNDROME

NCT01840410 TURKEY NOVARTIS DRUG 1. PLANNING 3 18712

YEARS N/A


NCT01930188 TURKEY NOVO NORDISK


YEARS N/A DIABETES

NCT01928979 UKRAINE BAYER OTHER 1. PLANNING NA 15018

YEARS N/A

ATRIAL FIBRILLATION

NCT01393626 UKRAINE PFIZER DRUG 2. RECRUITING 2 27518

YEARS 75


NCT01628393 UKRAINE RECEPTOS DRUG 2. RECRUITING 2 21018

YEARS 55


NCT01868061 UKRAINE HOFFMANN-LA ROCHE


YEARS 75

YEARS ASTHMA

NCT01928459 UK NOVARTIS DRUG 1. PLANNING 1 5518


NCT01853228 UK JANSSEN DRUG 1. PLANNING 2 27 1 MONTH 18 YEARS LEUKEMIA

NCT01945762 UK ASTRAZENECA DRUG 1. PLANNING NA 8018

YEARS N/A

THYROID CANCER

NCT01944735 UK CELTAXSYS DRUG 2. RECRUITING 1 3618

YEARS 55


NCT01945710 UK EISAI DRUG 2. RECRUITING 1 9618


NCT01945346 UK PROXIMAGEN DRUG 2. RECRUITING 2 7445

YEARS 75

YEARS OSTEOARTHRI-TIS, KNEE

NCT01948401 UK HOFFMANN-LA ROCHE


YEARS 75

YEARS ASTHMA

NCT01752322 UK GRENENTHAL DRUG 2. RECRUITING 3 60018

YEARS N/A

POSTOPERATIVE PAIN

NCT01868061 UK HOFFMANN-LA ROCHE


YEARS 75

YEARS ASTHMA

NCT01478438 UK NOVIAN DEVICE 2. RECRUITING NA 6018

YEARS 80

YEARS MALIGNANT TUMOR

NCT01947998 UK BAYER DRUG 2. RECRUITING NA 20,000 2 YEARS 89


NCT01946789 USA ALTOR BIOLOGICAL 1. PLANNING 1 2018

YEARS N/A MELANOMA

NCT01947569 USA DIAVACS BIOLOGICAL 1. PLANNING 1 9012

YEARS 35

YEARS DIABETES

NCT01947777 USA INFINITY DRUG 1. PLANNING 1 1418

YEARS 50

YEARS HEALTHY

NCT01949103 USA THERAVANCE DRUG 1. PLANNING 1 4818

YEARS 55


NCT01946945 USA REPROGENET-ICS

GENETIC 1. PLANNING 2 24022

YEARS 42

YEARS

RECURRENT PREGNANCY LOSS




(Return to Page 1)



























miN aGe

maX aGe CoNdiTioN

NCT01949324 USA NEUROTECH BIOLOGICAL 1. PLANNING 2 6821

YEARS 80

YEARS MACULAR TEL-ANGIECTASIA

NCT01946412 USA VERTEX DRUG 1. PLANNING 3MISS-ING

2 YEARS N/A CYSTIC FIBROSIS

NCT01947491 USA PROMIUS DRUG 1. PLANNING 3 39618

YEARS N/A PSORIASIS

NCT01949142 USA OTONOMY DRUG 1. PLANNING 3 2646

MONTHS 12

YEARS

TYMPANOS-TOMY TUBE PLACEMENT

NCT01949155 USA OTONOMY DRUG 1. PLANNING 3 2646

MONTHS 12

YEARS

TYMPANOS-TOMY TUBE PLACEMENT

NCT01945489 USA ALLERGAN BIOLOGICAL 1. PLANNING 4 25818

YEARS N/A

OVERACTIVE BLADDER

NCT01946126 USA ALLERGAN 1. PLANNING NA 20018

YEARS 65

YEARS HEADACHE

NCT01691807 USA GSK DRUG 2. RECRUITING 1 7018

YEARS N/A CANCER

NCT01944683 USA ACORDA OTHER 2. RECRUITING 1 2818

YEARS 75

YEARS HEART FAILURE

NCT01946074 USA ABBVIE DRUG 2. RECRUITING 1 7518


NCT01946568 USA DURATA DRUG 2. RECRUITING 1 363

MONTHS 11


NCT01948024 USA BIORASI DRUG 2. RECRUITING 1 6618

YEARS 80


NCT01885195 USA NOVARTIS DRUG 2. RECRUITING 2 7018

YEARS N/A

SOLID HEMATOLOGIC MALIGNANCIES

NCT01886378 USA ULTRAGENYX DRUG 2. RECRUITING 2 20 6 YEARS 25

YEARS LCHAD DEFICIENCY

NCT01891305 USA VIAMET DRUG 2. RECRUITING 2 4818

YEARS 65

YEARS TINEA PEDIS

NCT01941836 USA ESPERION DRUG 2. RECRUITING 2 32218

YEARS 80

YEARS HYPERCHOLES-TEROLEMIA

NCT01623310 USA OPTINOSE DRUG 2. RECRUITING 3 20018

YEARS N/A SINUSITIS

NCT01623323 USA OPTINOSE DRUG 2. RECRUITING 3 70018

YEARS N/A SINUSITIS

NCT01944839 USA OPHTHOTECH DRUG 2. RECRUITING 3 62250

YEARS N/A


NCT01945775 USA BIOMARIN DRUG 2. RECRUITING 3 42918

YEARS N/A

BRCA 2 GENE MUTATION

NCT01946243 USA AVID DRUG 2. RECRUITING 4 96 N/A N/A ALZHEIMERS DISEASE

NCT01946425 USA SANOFI BIOLOGICAL 2. RECRUITING 4 606

MONTHS 8 YEARS INFLUENZA

NCT01946438 USA SANOFI BIOLOGICAL 2. RECRUITING 4 20818

YEARS N/A INFLUENZA




(Return to Page 1)


























miN aGe

maX aGe CoNdiTioN

NCT01944670 USA SKELETAL DEVICE 2. RECRUITING NA 2521

YEARS N/A

CHRONIC ELBOW DISLOCATION

NCT01944748 USA RAND BEHAVIORAL 2. RECRUITING NA 20012

YEARS 19

YEARS FAMILY FUNCTIONING

NCT01945424 USA SANOFI BIOLOGICAL 2. RECRUITING NA 50018

YEARS N/A INFLUENZA

NCT01946581 USA MDBACKLINE PROCEDURE 2. RECRUITING NA 20018

YEARS 90

YEARS CATARACT

NCT01948427 USA HYPERION 2. RECRUITING NA 500 N/A N/A UREA CYCLE DISORDER

NCT01948544 USA STRATIHEALTH 2. RECRUITING NA 3065

YEARS 85

YEARS COPD

NCT01949584 USA INSLEEP DEVICE 2. RECRUITING NA 3018

YEARS N/A




(See Studies opening additional Sites in a Country, Page 25)

STudieS opeNiNG addiTioNal SiTeS iN a CouNTry

This table lists studies that launched additional sites in a country in the past week.


miN aGe

maX aGe CoNdiTioN

NCT01697579 ARGENTINA MERCK DRUG 2. RECRUITING 2 256 N/A 17

YEARS


NCT01201356 ARGENTINA NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01663402 ARGENTINA SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01682512 ARGENTINA BOEHRINGER INGELHEIM


YEARS 80


NCT01868061 ARGENTINA HOFFMANN-LA ROCHE


YEARS 75

YEARS ASTHMA

NCT01574703 ARGENTINA PFIZER DRUG 2. RECRUITING 4 8,00018

YEARS 75


NCT01511913 ARGENTINA BMS 2. RECRUITING NA 1,80018

YEARS N/A MELANOMA

NCT01907100 AUSTRALIA BOEHRINGER INGELHEIM



NCT01840410 AUSTRALIA NOVARTIS DRUG 1. PLANNING 3 18712

YEARS N/A


NCT01295827 AUSTRALIA MERCK DRUG 2. RECRUITING 1 1,06718

YEARS N/A SOLID TUMOR

NCT01393626 AUSTRALIA PFIZER DRUG 2. RECRUITING 2 27518

YEARS 75


NCT01740336 AUSTRALIA GENENTECH DRUG 2. RECRUITING 2 18018


(Return to Page 1)






















miN aGe

maX aGe CoNdiTioN

NCT01762852 AUSTRALIA GSK DRUG 2. RECRUITING 2 9418

YEARS 75

YEARS GLOMERULONE-PHRITIS

NCT01843374 AUSTRALIA MEDIMMUNE DRUG 2. RECRUITING 2 18018


NCT00625378 AUSTRALIA BAYER DRUG 2. RECRUITING 3 1,00016

YEARS N/A NEOPLASMS

NCT01201356 AUSTRALIA NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01480479 AUSTRALIA CELLDEX DRUG 2. RECRUITING 3 44018

YEARS N/A GLIOBLASTOMA

NCT01489111 AUSTRALIA NOVO NORDISK



NCT01560624 AUSTRALIA UNITED THERAPEUTICS


YEARS 75


NCT01560637 AUSTRALIA UNITED THERAPEUTICS


YEARS 75


NCT01566695 AUSTRALIA CELGENE DRUG 2. RECRUITING 3 38618

YEARS N/A

MYELODYSPLAS-TIC

NCT01641926 AUSTRALIA MERCK BIOLOGICAL 2. RECRUITING 3 1,40018

YEARS N/A


NCT01663402 AUSTRALIA SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01703208 AUSTRALIA MERCK DRUG 2. RECRUITING 3 4,00040

YEARS N/A DIABETES

NCT01708174 AUSTRALIA NOVARTIS DRUG 2. RECRUITING 3 109 N/A N/A MEDULLOBLAS-TOMA

NCT01734785 AUSTRALIA BOEHRINGER INGELHEIM


YEARS N/A DIABETES

NCT01767467 AUSTRALIA GSK BIOLOGICAL 2. RECRUITING 3 50218

YEARS N/A HERPES ZOSTER

NCT01828099 AUSTRALIA NOVARTIS DRUG 2. RECRUITING 3 34818


NCT01846611 AUSTRALIA JANSSEN DRUG 2. RECRUITING 3 67018

YEARS N/A


NCT01868061 AUSTRALIA HOFFMANN-LA ROCHE


YEARS 75

YEARS ASTHMA

NCT00867815 AUSTRALIA BAYER DRUG 2. RECRUITING 4 28440

YEARS N/A

OPTIC NEUROPATHY

NCT01574703 AUSTRALIA PFIZER DRUG 2. RECRUITING 4 8,00018

YEARS 75


NCT01511913 AUSTRALIA BMS 2. RECRUITING NA 1,80018

YEARS N/A MELANOMA

NCT01393626 AUSTRIA PFIZER DRUG 2. RECRUITING 2 27518

YEARS 75


NCT01697579 AUSTRIA MERCK DRUG 2. RECRUITING 2 256 N/A 17

YEARS




Studies opening additional Sites in a Country, from Page 24

(Return to Page 1)


























miN aGe

maX aGe CoNdiTioN

NCT01740336 AUSTRIA GENENTECH DRUG 2. RECRUITING 2 18018


NCT01201356 AUSTRIA NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01480479 AUSTRIA CELLDEX DRUG 2. RECRUITING 3 44018


NCT01560624 AUSTRIA UNITED THERAPEUTICS


YEARS 75


NCT01560637 AUSTRIA UNITED THERAPEUTICS


YEARS 75


NCT01663402 AUSTRIA SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01703208 AUSTRIA MERCK DRUG 2. RECRUITING 3 4,00040

YEARS N/A DIABETES

NCT01752322 AUSTRIA GRENENTHAL DRUG 2. RECRUITING 3 60018

YEARS N/A

POSTOPERATIVE PAIN

NCT01828099 AUSTRIA NOVARTIS DRUG 2. RECRUITING 3 34818


NCT01511913 AUSTRIA BMS 2. RECRUITING NA 1,80018

YEARS N/A MELANOMA

NCT01671007 AUSTRIA BOEHRINGER INGELHEIM


YEARS N/A

ATRIAL FIBRILLATION

NCT01840410 BELGIUM NOVARTIS DRUG 1. PLANNING 3 18712

YEARS N/A


NCT01895777 BELGIUM BOEHRINGER INGELHEIM


YEARS THROMBOEMBO-LISM

NCT01628393 BELGIUM RECEPTOS DRUG 2. RECRUITING 2 21018

YEARS 55


NCT01740336 BELGIUM GENENTECH DRUG 2. RECRUITING 2 18018


NCT01767090 BELGIUM ASTELLAS DRUG 2. RECRUITING 2 60018

YEARS 45

YEARS ENDOMETRIOSIS

NCT00625378 BELGIUM BAYER DRUG 2. RECRUITING 3 1,00016

YEARS N/A NEOPLASMS

NCT01201356 BELGIUM NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01566695 BELGIUM CELGENE DRUG 2. RECRUITING 3 38618

YEARS N/A

MYELODYSPLAS-TIC

NCT01663402 BELGIUM SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01682512 BELGIUM BOEHRINGER INGELHEIM


YEARS 80


NCT01703208 BELGIUM MERCK DRUG 2. RECRUITING 3 4,00040

YEARS N/A DIABETES

NCT01752322 BELGIUM GRENENTHAL DRUG 2. RECRUITING 3 60018

YEARS N/A

POSTOPERATIVE PAIN




(Return to Page 1)


























miN aGe

maX aGe CoNdiTioN

NCT01757405 BELGIUM BAXTER BIOLOGICAL 2. RECRUITING 3 3412

YEARS 65

YEARS HEMOPHILIA B

NCT01767467 BELGIUM GSK BIOLOGICAL 2. RECRUITING 3 50218


NCT01868061 BELGIUM HOFFMANN-LA ROCHE


YEARS 75

YEARS ASTHMA

NCT01697358 BELGIUM MEDTRONIC DEVICE 2. RECRUITING 4 30018

YEARS N/A PAIN IN LEG

NCT01791361 BELGIUM AMGEN OTHER 2. RECRUITING NA 45018

YEARS N/A

COLORECTAL CANCER

NCT01835431 BRAZIL NOVO NORDISK


YEARS DIABETES

NCT00625378 BRAZIL BAYER DRUG 2. RECRUITING 3 1,00016

YEARS N/A NEOPLASMS

NCT01201356 BRAZIL NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01480479 BRAZIL CELLDEX DRUG 2. RECRUITING 3 44018


NCT01663402 BRAZIL SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01708174 BRAZIL NOVARTIS DRUG 2. RECRUITING 3 109 N/A N/A MEDULLOBLAS-TOMA

NCT01731600 BRAZIL NOVO NORDISK


YEARS HAEMOPHILIA A

NCT01734785 BRAZIL BOEHRINGER INGELHEIM


YEARS N/A DIABETES

NCT01828099 BRAZIL NOVARTIS DRUG 2. RECRUITING 3 34818


NCT01511913 BRAZIL BMS 2. RECRUITING NA 1,80018

YEARS N/A MELANOMA

NCT01928979 BULGARIA BAYER OTHER 1. PLANNING NA 15018

YEARS N/A

ATRIAL FIBRILLATION

NCT01393626 BULGARIA PFIZER DRUG 2. RECRUITING 2 27518

YEARS 75


NCT01628393 BULGARIA RECEPTOS DRUG 2. RECRUITING 2 21018

YEARS 55


NCT01767090 BULGARIA ASTELLAS DRUG 2. RECRUITING 2 60018

YEARS 45

YEARS ENDOMETRIOSIS

NCT00625378 BULGARIA BAYER DRUG 2. RECRUITING 3 1,00016

YEARS N/A NEOPLASMS

NCT01479244 BULGARIA GALENA BIOLOGICAL 2. RECRUITING 3 70018


NCT01663402 BULGARIA SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01682512 BULGARIA BOEHRINGER INGELHEIM


YEARS 80





(Return to Page 1)


























miN aGe

maX aGe CoNdiTioN

NCT01703208 BULGARIA MERCK DRUG 2. RECRUITING 3 4,00040

YEARS N/A DIABETES

NCT01868061 BULGARIA HOFFMANN-LA ROCHE


YEARS 75

YEARS ASTHMA

NCT01574703 BULGARIA PFIZER DRUG 2. RECRUITING 4 8,00018

YEARS 75


NCT01671007 BULGARIA BOEHRINGER INGELHEIM


YEARS N/A

ATRIAL FIBRILLATION

NCT01840410 CANADA NOVARTIS DRUG 1. PLANNING 3 18712

YEARS N/A


NCT01295827 CANADA MERCK DRUG 2. RECRUITING 1 1,06718


NCT01393626 CANADA PFIZER DRUG 2. RECRUITING 2 27518

YEARS 75



YEARS 65

YEARS ASTHMA

NCT01697579 CANADA MERCK DRUG 2. RECRUITING 2 256 N/A 17

YEARS


NCT01762852 CANADA GSK DRUG 2. RECRUITING 2 9418

YEARS 75


NCT00625378 CANADA BAYER DRUG 2. RECRUITING 3 1,00016

YEARS N/A NEOPLASMS

NCT01201356 CANADA NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01479244 CANADA GALENA BIOLOGICAL 2. RECRUITING 3 70018


NCT01480479 CANADA CELLDEX DRUG 2. RECRUITING 3 44018


NCT01560624 CANADA UNITED THERAPEUTICS


YEARS 75


NCT01560637 CANADA UNITED THERAPEUTICS


YEARS 75


NCT01566695 CANADA CELGENE DRUG 2. RECRUITING 3 38618

YEARS N/A

MYELODYSPLAS-TIC

NCT01663402 CANADA SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A




YEARS 80



YEARS N/A DIABETES

NCT01708174 CANADA NOVARTIS DRUG 2. RECRUITING 3 109 N/A N/A MEDULLOBLAS-TOMA

NCT01731600 CANADA NOVO NORDISK


YEARS HAEMOPHILIA A

NCT01767467 CANADA GSK BIOLOGICAL 2. RECRUITING 3 50218





(Return to Page 1)


























miN aGe

maX aGe CoNdiTioN

NCT01868061 CANADA HOFFMANN-LA ROCHE


YEARS 75

YEARS ASTHMA

NCT00867815 CANADA BAYER DRUG 2. RECRUITING 4 28440

YEARS N/A

OPTIC NEUROPATHY

NCT01574703 CANADA PFIZER DRUG 2. RECRUITING 4 8,00018

YEARS 75


NCT01511913 CANADA BMS 2. RECRUITING NA 1,80018

YEARS N/A MELANOMA

NCT01697579 CHILE MERCK DRUG 2. RECRUITING 2 256 N/A 17

YEARS


NCT01663402 CHILE SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT00625378 CHINA BAYER DRUG 2. RECRUITING 3 1,00016

YEARS N/A NEOPLASMS

NCT01560624 CHINA UNITED THERAPEUTICS


YEARS 75


NCT01560637 CHINA UNITED THERAPEUTICS


YEARS 75


NCT01922102 CHINA NOVARTIS DRUG 2. RECRUITING 3 47518

YEARS N/A

VISUAL IMPAIRMENT

NCT01697579 COLOMBIA MERCK DRUG 2. RECRUITING 2 256 N/A 17

YEARS


NCT00625378 COLOMBIA BAYER DRUG 2. RECRUITING 3 1,00016

YEARS N/A NEOPLASMS

NCT01480479 COLOMBIA CELLDEX DRUG 2. RECRUITING 3 44018


NCT01641926 COLOMBIA MERCK BIOLOGICAL 2. RECRUITING 3 1,40018

YEARS N/A


NCT01663402 COLOMBIA SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01828099 COLOMBIA NOVARTIS DRUG 2. RECRUITING 3 34818


NCT01489111 CROATIA NOVO NORDISK



NCT01682759 CROATIA MERCK DRUG 2. RECRUITING 3 68018

YEARS N/A DIABETES

NCT01671007 CROATIA BOEHRINGER INGELHEIM


YEARS N/A

ATRIAL FIBRILLATION

NCT01835431 CZECH REP NOVO NORDISK


YEARS DIABETES

NCT01895777 CZECH REP BOEHRINGER INGELHEIM





YEARS 70

YEARS HEALTHY




(Return to Page 1)

























miN aGe

maX aGe CoNdiTioN

NCT01393626 CZECH REP PFIZER DRUG 2. RECRUITING 2 27518

YEARS 75


NCT01740336 CZECH REP GENENTECH DRUG 2. RECRUITING 2 18018


NCT01201356 CZECH REP NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01479244 CZECH REP GALENA BIOLOGICAL 2. RECRUITING 3 70018


NCT01480479 CZECH REP CELLDEX DRUG 2. RECRUITING 3 44018


NCT01566695 CZECH REP CELGENE DRUG 2. RECRUITING 3 38618

YEARS N/A

MYELODYSPLAS-TIC

NCT01663402 CZECH REP SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01703208 CZECH REP MERCK DRUG 2. RECRUITING 3 4,00040

YEARS N/A DIABETES



YEARS N/A

ATRIAL FIBRILLATION

NCT01907100 DENMARK BOEHRINGER INGELHEIM



NCT01840410 DENMARK NOVARTIS DRUG 1. PLANNING 3 18712

YEARS N/A


NCT01201356 DENMARK NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01566695 DENMARK CELGENE DRUG 2. RECRUITING 3 38618

YEARS N/A

MYELODYSPLAS-TIC

NCT01663402 DENMARK SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01703208 DENMARK MERCK DRUG 2. RECRUITING 3 4,00040

YEARS N/A DIABETES

NCT01752322 DENMARK GRENENTHAL DRUG 2. RECRUITING 3 60018

YEARS N/A

POSTOPERATIVE PAIN

NCT01671007 DENMARK BOEHRINGER INGELHEIM


YEARS N/A

ATRIAL FIBRILLATION

NCT01791361 DENMARK AMGEN OTHER 2. RECRUITING NA 45018

YEARS N/A

COLORECTAL CANCER

NCT01201356 EGYPT NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01734785 EL SALVADOR BOEHRINGER INGELHEIM


YEARS N/A DIABETES

NCT01671007 EL SALVADOR BOEHRINGER INGELHEIM


YEARS N/A

ATRIAL FIBRILLATION

NCT01697579 ESTONIA MERCK DRUG 2. RECRUITING 2 256 N/A 17

YEARS


NCT01201356 ESTONIA NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS




(Return to Page 1)


























miN aGe

maX aGe CoNdiTioN

NCT01663402 ESTONIA SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01682512 ESTONIA BOEHRINGER INGELHEIM


YEARS 80


NCT01671007 ESTONIA BOEHRINGER INGELHEIM


YEARS N/A

ATRIAL FIBRILLATION

NCT01201356 FINLAND NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01566695 FINLAND CELGENE DRUG 2. RECRUITING 3 38618

YEARS N/A

MYELODYSPLAS-TIC

NCT01663402 FINLAND SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01767467 FINLAND GSK BIOLOGICAL 2. RECRUITING 3 50218


NCT01574703 FINLAND PFIZER DRUG 2. RECRUITING 4 8,00018

YEARS 75


NCT01907100 FRANCE BOEHRINGER INGELHEIM



NCT01928979 FRANCE BAYER OTHER 1. PLANNING NA 15018

YEARS N/A

ATRIAL FIBRILLATION

NCT01295827 FRANCE MERCK DRUG 2. RECRUITING 1 1,06718


NCT01393626 FRANCE PFIZER DRUG 2. RECRUITING 2 27518

YEARS 75


NCT01656395 FRANCE MERCK DRUG 2. RECRUITING 2 1,47518

YEARS 65

YEARS ASTHMA

NCT01762852 FRANCE GSK DRUG 2. RECRUITING 2 9418

YEARS 75


NCT00625378 FRANCE BAYER DRUG 2. RECRUITING 3 1,00016

YEARS N/A NEOPLASMS

NCT01201356 FRANCE NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01489111 FRANCE NOVO NORDISK



NCT01560624 FRANCE UNITED THERAPEUTICS


YEARS 75


NCT01560637 FRANCE UNITED THERAPEUTICS


YEARS 75


NCT01663402 FRANCE SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A




YEARS 80


NCT01708174 FRANCE NOVARTIS DRUG 2. RECRUITING 3 109 N/A N/A MEDULLOBLAS-TOMA

NCT01731600 FRANCE NOVO NORDISK


YEARS HAEMOPHILIA A




(Return to Page 1)


























miN aGe

maX aGe CoNdiTioN



YEARS N/A DIABETES

NCT01752322 FRANCE GRENENTHAL DRUG 2. RECRUITING 3 60018

YEARS N/A

POSTOPERATIVE PAIN

NCT01767467 FRANCE GSK BIOLOGICAL 2. RECRUITING 3 50218


NCT01828099 FRANCE NOVARTIS DRUG 2. RECRUITING 3 34818


NCT01828112 FRANCE NOVARTIS DRUG 2. RECRUITING 3 23618


NCT01868061 FRANCE HOFFMANN-LA ROCHE


YEARS 75

YEARS ASTHMA

NCT01697358 FRANCE MEDTRONIC DEVICE 2. RECRUITING 4 30018


NCT01511913 FRANCE BMS 2. RECRUITING NA 1,80018

YEARS N/A MELANOMA



YEARS N/A

ATRIAL FIBRILLATION

NCT01791361 FRANCE AMGEN OTHER 2. RECRUITING NA 45018

YEARS N/A

COLORECTAL CANCER

NCT01628393 GEORGIA RECEPTOS DRUG 2. RECRUITING 2 21018

YEARS 55


NCT01703208 GEORGIA MERCK DRUG 2. RECRUITING 3 4,00040

YEARS N/A DIABETES




NCT01928979 GERMANY BAYER OTHER 1. PLANNING NA 15018

YEARS N/A

ATRIAL FIBRILLATION



YEARS 70

YEARS HEALTHY

NCT01393626 GERMANY PFIZER DRUG 2. RECRUITING 2 27518

YEARS 75


NCT01656395 GERMANY MERCK DRUG 2. RECRUITING 2 1,47518

YEARS 65

YEARS ASTHMA

NCT01697579 GERMANY MERCK DRUG 2. RECRUITING 2 256 N/A 17

YEARS


NCT01762852 GERMANY GSK DRUG 2. RECRUITING 2 9418

YEARS 75


NCT00625378 GERMANY BAYER DRUG 2. RECRUITING 3 1,00016

YEARS N/A NEOPLASMS

NCT01201356 GERMANY NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01489111 GERMANY NOVO NORDISK



NCT01560624 GERMANY UNITED THERAPEUTICS


YEARS 75





(Return to Page 1)


























miN aGe

maX aGe CoNdiTioN

NCT01560637 GERMANY UNITED THERAPEUTICS


YEARS 75


NCT01566695 GERMANY CELGENE DRUG 2. RECRUITING 3 38618

YEARS N/A

MYELODYSPLAS-TIC

NCT01663402 GERMANY SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A




YEARS 80


NCT01682759 GERMANY MERCK DRUG 2. RECRUITING 3 68018

YEARS N/A DIABETES

NCT01703208 GERMANY MERCK DRUG 2. RECRUITING 3 4,00040

YEARS N/A DIABETES

NCT01708174 GERMANY NOVARTIS DRUG 2. RECRUITING 3 109 N/A N/A MEDULLOBLAS-TOMA

NCT01731600 GERMANY NOVO NORDISK


YEARS HAEMOPHILIA A





NCT01868061 GERMANY HOFFMANN-LA ROCHE


YEARS 75

YEARS ASTHMA

NCT00867815 GERMANY BAYER DRUG 2. RECRUITING 4 28440

YEARS N/A

OPTIC NEUROPATHY

NCT01574703 GERMANY PFIZER DRUG 2. RECRUITING 4 8,00018

YEARS 75


NCT01697358 GERMANY MEDTRONIC DEVICE 2. RECRUITING 4 30018


NCT01511913 GERMANY BMS 2. RECRUITING NA 1,80018

YEARS N/A MELANOMA

NCT01598844 GERMANY JENAVALVE DEVICE 2. RECRUITING NA 180 N/A N/A AORTIC STENOSIS



YEARS N/A

ATRIAL FIBRILLATION

NCT01791361 GERMANY AMGEN OTHER 2. RECRUITING NA 45018

YEARS N/A

COLORECTAL CANCER

NCT01916278 GERMANY Q-MED DEVICE 2. RECRUITING NA MISS-ING

18 YEARS

65 YEARS


NCT01393626 GREECE PFIZER DRUG 2. RECRUITING 2 27518

YEARS 75


NCT01697579 GREECE MERCK DRUG 2. RECRUITING 2 256 N/A 17

YEARS


NCT01201356 GREECE NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01480479 GREECE CELLDEX DRUG 2. RECRUITING 3 44018





(Return to Page 1)


























miN aGe

maX aGe CoNdiTioN

NCT01731600 GREECE NOVO NORDISK


YEARS HAEMOPHILIA A

NCT01828099 GREECE NOVARTIS DRUG 2. RECRUITING 3 34818


NCT01671007 GREECE BOEHRINGER INGELHEIM


YEARS N/A

ATRIAL FIBRILLATION

NCT01201356 GUATEMALA NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT00625378 HONG KONG BAYER DRUG 2. RECRUITING 3 1,00016

YEARS N/A NEOPLASMS

NCT01663402 HONG KONG SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01703208 HONG KONG MERCK DRUG 2. RECRUITING 3 4,00040

YEARS N/A DIABETES

NCT01767467 HONG KONG GSK BIOLOGICAL 2. RECRUITING 3 50218


NCT01828112 HONG KONG NOVARTIS DRUG 2. RECRUITING 3 23618


NCT01840410 HUNGARY NOVARTIS DRUG 1. PLANNING 3 18712

YEARS N/A


NCT01393626 HUNGARY PFIZER DRUG 2. RECRUITING 2 27518

YEARS 75


NCT01697579 HUNGARY MERCK DRUG 2. RECRUITING 2 256 N/A 17

YEARS


NCT01767090 HUNGARY ASTELLAS DRUG 2. RECRUITING 2 60018

YEARS 45

YEARS ENDOMETRIOSIS

NCT01201356 HUNGARY NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01479244 HUNGARY GALENA BIOLOGICAL 2. RECRUITING 3 70018


NCT01480479 HUNGARY CELLDEX DRUG 2. RECRUITING 3 44018


NCT01489111 HUNGARY NOVO NORDISK



NCT01663402 HUNGARY SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01682512 HUNGARY BOEHRINGER INGELHEIM


YEARS 80


NCT01682759 HUNGARY MERCK DRUG 2. RECRUITING 3 68018

YEARS N/A DIABETES

NCT01703208 HUNGARY MERCK DRUG 2. RECRUITING 3 4,00040

YEARS N/A DIABETES

NCT01708174 HUNGARY NOVARTIS DRUG 2. RECRUITING 3 109 N/A N/A MEDULLOBLAS-TOMA

NCT01828099 HUNGARY NOVARTIS DRUG 2. RECRUITING 3 34818





(Return to Page 1)




























miN aGe

maX aGe CoNdiTioN

NCT01868061 HUNGARY HOFFMANN-LA ROCHE


YEARS 75

YEARS ASTHMA

NCT01480479 INDIA CELLDEX DRUG 2. RECRUITING 3 44018


NCT01757405 INDIA BAXTER BIOLOGICAL 2. RECRUITING 3 3412

YEARS 65

YEARS HEMOPHILIA B

NCT01828099 INDIA NOVARTIS DRUG 2. RECRUITING 3 34818


NCT01201356 IRELAND NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01682512 IRELAND BOEHRINGER INGELHEIM


YEARS 80


NCT01511913 IRELAND BMS 2. RECRUITING NA 1,80018

YEARS N/A MELANOMA

NCT01201356 ISRAEL NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01479244 ISRAEL GALENA BIOLOGICAL 2. RECRUITING 3 70018


NCT01663402 ISRAEL SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01703208 ISRAEL MERCK DRUG 2. RECRUITING 3 4,00040

YEARS N/A DIABETES

NCT01708174 ISRAEL NOVARTIS DRUG 2. RECRUITING 3 109 N/A N/A MEDULLOBLAS-TOMA

NCT01731600 ISRAEL NOVO NORDISK


YEARS HAEMOPHILIA A

NCT01828112 ISRAEL NOVARTIS DRUG 2. RECRUITING 3 23618


NCT01841684 ISRAEL MERCK DRUG 2. RECRUITING 3 4518

YEARS N/A


NCT01846611 ISRAEL JANSSEN DRUG 2. RECRUITING 3 67018

YEARS N/A


NCT01868061 ISRAEL HOFFMANN-LA ROCHE


YEARS 75

YEARS ASTHMA

NCT01511913 ISRAEL BMS 2. RECRUITING NA 1,80018

YEARS N/A MELANOMA




NCT01840410 ITALY NOVARTIS DRUG 1. PLANNING 3 18712

YEARS N/A


NCT01628393 ITALY RECEPTOS DRUG 2. RECRUITING 2 21018

YEARS 55


NCT01656395 ITALY MERCK DRUG 2. RECRUITING 2 1,47518

YEARS 65

YEARS ASTHMA

NCT01697579 ITALY MERCK DRUG 2. RECRUITING 2 256 N/A 17

YEARS



(Return to Page 1)




























miN aGe

maX aGe CoNdiTioN

NCT01762852 ITALY GSK DRUG 2. RECRUITING 2 9418

YEARS 75


NCT00625378 ITALY BAYER DRUG 2. RECRUITING 3 1,00016

YEARS N/A NEOPLASMS

NCT01201356 ITALY NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS




NCT01560624 ITALY UNITED THERAPEUTICS


YEARS 75


NCT01560637 ITALY UNITED THERAPEUTICS


YEARS 75


NCT01566695 ITALY CELGENE DRUG 2. RECRUITING 3 38618

YEARS N/A

MYELODYSPLAS-TIC

NCT01663402 ITALY SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A




YEARS 80


NCT01703208 ITALY MERCK DRUG 2. RECRUITING 3 4,00040

YEARS N/A DIABETES

NCT01708174 ITALY NOVARTIS DRUG 2. RECRUITING 3 109 N/A N/A MEDULLOBLAS-TOMA



YEARS HAEMOPHILIA A

NCT01752322 ITALY GRENENTHAL DRUG 2. RECRUITING 3 60018

YEARS N/A

POSTOPERATIVE PAIN

NCT01767467 ITALY GSK BIOLOGICAL 2. RECRUITING 3 50218


NCT01828099 ITALY NOVARTIS DRUG 2. RECRUITING 3 34818


NCT01828112 ITALY NOVARTIS DRUG 2. RECRUITING 3 23618


NCT01868061 ITALY HOFFMANN-LA ROCHE


YEARS 75

YEARS ASTHMA

NCT00867815 ITALY BAYER DRUG 2. RECRUITING 4 28440

YEARS N/A

OPTIC NEUROPATHY

NCT01393626 JAPAN PFIZER DRUG 2. RECRUITING 2 27518

YEARS 75


NCT01656395 JAPAN MERCK DRUG 2. RECRUITING 2 1,47518

YEARS 65

YEARS ASTHMA

NCT01767090 JAPAN ASTELLAS DRUG 2. RECRUITING 2 60018

YEARS 45

YEARS ENDOMETRIOSIS

NCT01098110 JAPAN MERCK DRUG 2. RECRUITING 3 52820

YEARS 64

YEARS SCHIZOPHRENIA

NCT01489111 JAPAN NOVO NORDISK



NCT01731600 JAPAN NOVO NORDISK


YEARS HAEMOPHILIA A


(Return to Page 1)




























miN aGe

maX aGe CoNdiTioN

NCT01757405 JAPAN BAXTER BIOLOGICAL 2. RECRUITING 3 3412

YEARS 65

YEARS HEMOPHILIA B

NCT01828099 JAPAN NOVARTIS DRUG 2. RECRUITING 3 34818


NCT01828112 JAPAN NOVARTIS DRUG 2. RECRUITING 3 23618


NCT01868061 JAPAN HOFFMANN-LA ROCHE


YEARS 75

YEARS ASTHMA

NCT01393626 KOREA, SOUTH PFIZER DRUG 2. RECRUITING 2 27518

YEARS 75


NCT00625378 KOREA, SOUTH BAYER DRUG 2. RECRUITING 3 1,00016

YEARS N/A NEOPLASMS

NCT01098110 KOREA, SOUTH MERCK DRUG 2. RECRUITING 3 52820

YEARS 64

YEARS SCHIZOPHRENIA

NCT01201356 KOREA, SOUTH NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01489111 KOREA, SOUTH NOVO NORDISK



NCT01560624 KOREA, SOUTH UNITED THERAPEUTICS


YEARS 75


NCT01560637 KOREA, SOUTH UNITED THERAPEUTICS


YEARS 75


NCT01641926 KOREA, SOUTH MERCK BIOLOGICAL 2. RECRUITING 3 1,40018

YEARS N/A


NCT01663402 KOREA, SOUTH SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01682759 KOREA, SOUTH MERCK DRUG 2. RECRUITING 3 68018

YEARS N/A DIABETES

NCT01703208 KOREA, SOUTH MERCK DRUG 2. RECRUITING 3 4,00040

YEARS N/A DIABETES

NCT01734785 KOREA, SOUTH BOEHRINGER INGELHEIM


YEARS N/A DIABETES

NCT01767467 KOREA, SOUTH GSK BIOLOGICAL 2. RECRUITING 3 50218


NCT01840410 LATVIA NOVARTIS DRUG 1. PLANNING 3 18712

YEARS N/A


NCT01663402 LATVIA SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01671007 LATVIA BOEHRINGER INGELHEIM


YEARS N/A

ATRIAL FIBRILLATION

NCT01682759 LEBANON MERCK DRUG 2. RECRUITING 3 68018

YEARS N/A DIABETES

NCT01703208 LEBANON MERCK DRUG 2. RECRUITING 3 4,00040

YEARS N/A DIABETES

NCT01828099 LEBANON NOVARTIS DRUG 2. RECRUITING 3 34818



(See Studies opening additional Sites in a Country, Page 38)(Return to Page 1)




























miN aGe

maX aGe CoNdiTioN

NCT01840410 LITHUANIA NOVARTIS DRUG 1. PLANNING 3 18712

YEARS N/A


NCT01697579 LITHUANIA MERCK DRUG 2. RECRUITING 2 256 N/A 17

YEARS


NCT01663402 LITHUANIA SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01682759 LITHUANIA MERCK DRUG 2. RECRUITING 3 68018

YEARS N/A DIABETES

NCT01703208 LITHUANIA MERCK DRUG 2. RECRUITING 3 4,00040

YEARS N/A DIABETES

NCT01731600 LITHUANIA NOVO NORDISK


YEARS HAEMOPHILIA A

NCT01835431 MACEDONIA NOVO NORDISK


YEARS DIABETES

NCT01201356 MALAYSIA NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01489111 MALAYSIA NOVO NORDISK



NCT01663402 MALAYSIA SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01682759 MALAYSIA MERCK DRUG 2. RECRUITING 3 68018

YEARS N/A DIABETES

NCT01703208 MALAYSIA MERCK DRUG 2. RECRUITING 3 4,00040

YEARS N/A DIABETES

NCT01731600 MALAYSIA NOVO NORDISK


YEARS HAEMOPHILIA A

NCT01930188 MEXICO NOVO NORDISK


YEARS N/A DIABETES

NCT01480479 MEXICO CELLDEX DRUG 2. RECRUITING 3 44018


NCT01663402 MEXICO SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01511913 MEXICO BMS 2. RECRUITING NA 1,80018

YEARS N/A MELANOMA

NCT01751776 NETHERLANDS BOEHRINGER INGELHEIM


YEARS 70

YEARS HEALTHY

NCT01762852 NETHERLANDS GSK DRUG 2. RECRUITING 2 9418

YEARS 75


NCT01201356 NETHERLANDS NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01489111 NETHERLANDS NOVO NORDISK



NCT01560624 NETHERLANDS UNITED THERAPEUTICS


YEARS 75



(Return to Page 1)


























miN aGe

maX aGe CoNdiTioN

NCT01560637 NETHERLANDS UNITED THERAPEUTICS


YEARS 75


NCT01663402 NETHERLANDS SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A




YEARS 80


NCT01703208 NETHERLANDS MERCK DRUG 2. RECRUITING 3 4,00040

YEARS N/A DIABETES

NCT01708174 NETHERLANDS NOVARTIS DRUG 2. RECRUITING 3 109 N/A N/A MEDULLOBLAS-TOMA

NCT01828099 NETHERLANDS NOVARTIS DRUG 2. RECRUITING 3 34818


NCT01828112 NETHERLANDS NOVARTIS DRUG 2. RECRUITING 3 23618


NCT01697358 NETHERLANDS MEDTRONIC DEVICE 2. RECRUITING 4 30018




YEARS N/A DIABETES



YEARS N/A

ATRIAL FIBRILLATION

NCT01791361 NETHERLANDS AMGEN OTHER 2. RECRUITING NA 45018

YEARS N/A

COLORECTAL CANCER

NCT01911897 NETHERLANDS VASCULAR DYNAMICS

DEVICE 2. RECRUITING NA 2018

YEARS 80

YEARS HYPERTENSION

NCT01751776 NEW ZEALAND BOEHRINGER INGELHEIM


YEARS 70

YEARS HEALTHY

NCT00625378 NEW ZEALAND BAYER DRUG 2. RECRUITING 3 1,00016

YEARS N/A NEOPLASMS

NCT01480479 NEW ZEALAND CELLDEX DRUG 2. RECRUITING 3 44018


NCT01663402 NEW ZEALAND SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A




YEARS 80


NCT01703208 NEW ZEALAND MERCK DRUG 2. RECRUITING 3 4,00040

YEARS N/A DIABETES



YEARS N/A DIABETES

NCT01767467 NEW ZEALAND GSK BIOLOGICAL 2. RECRUITING 3 50218


NCT01846611 NEW ZEALAND JANSSEN DRUG 2. RECRUITING 3 67018

YEARS N/A


NCT01868061 NEW ZEALAND HOFFMANN-LA ROCHE


YEARS 75

YEARS ASTHMA

NCT01574703 NEW ZEALAND PFIZER DRUG 2. RECRUITING 4 8,00018

YEARS 75































miN aGe

maX aGe CoNdiTioN

NCT01295827 NORWAY MERCK DRUG 2. RECRUITING 1 1,06718


NCT01201356 NORWAY NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01489111 NORWAY NOVO NORDISK



NCT01663402 NORWAY SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A




YEARS N/A DIABETES

NCT01841684 NORWAY MERCK DRUG 2. RECRUITING 3 4518

YEARS N/A




YEARS N/A

ATRIAL FIBRILLATION

NCT01201356 PANAMA NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01767467 PANAMA GSK BIOLOGICAL 2. RECRUITING 3 50218


NCT01656395 PERU MERCK DRUG 2. RECRUITING 2 1,47518

YEARS 65

YEARS ASTHMA

NCT01201356 PERU NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01480479 PERU CELLDEX DRUG 2. RECRUITING 3 44018


NCT01663402 PERU SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01868061 PERU HOFFMANN-LA ROCHE


YEARS 75

YEARS ASTHMA

NCT01663402 PHILIPPINES SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01835431 POLAND NOVO NORDISK


YEARS DIABETES

NCT01840410 POLAND NOVARTIS DRUG 1. PLANNING 3 18712

YEARS N/A


NCT01928979 POLAND BAYER OTHER 1. PLANNING NA 15018

YEARS N/A

ATRIAL FIBRILLATION

NCT01628393 POLAND RECEPTOS DRUG 2. RECRUITING 2 21018

YEARS 55


NCT01767090 POLAND ASTELLAS DRUG 2. RECRUITING 2 60018

YEARS 45

YEARS ENDOMETRIOSIS

NCT00625378 POLAND BAYER DRUG 2. RECRUITING 3 1,00016

YEARS N/A NEOPLASMS

NCT01201356 POLAND NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01479244 POLAND GALENA BIOLOGICAL 2. RECRUITING 3 70018



(Return to Page 1)



























miN aGe

maX aGe CoNdiTioN

NCT01480479 POLAND CELLDEX DRUG 2. RECRUITING 3 44018


NCT01663402 POLAND SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01682512 POLAND BOEHRINGER INGELHEIM


YEARS 80


NCT01682759 POLAND MERCK DRUG 2. RECRUITING 3 68018

YEARS N/A DIABETES

NCT01703208 POLAND MERCK DRUG 2. RECRUITING 3 4,00040

YEARS N/A DIABETES

NCT01708174 POLAND NOVARTIS DRUG 2. RECRUITING 3 109 N/A N/A MEDULLOBLAS-TOMA

NCT01757405 POLAND BAXTER BIOLOGICAL 2. RECRUITING 3 3412

YEARS 65

YEARS HEMOPHILIA B

NCT01868061 POLAND HOFFMANN-LA ROCHE


YEARS 75

YEARS ASTHMA

NCT01840410 PORTUGAL NOVARTIS DRUG 1. PLANNING 3 18712

YEARS N/A


NCT01697579 PORTUGAL MERCK DRUG 2. RECRUITING 2 256 N/A 17

YEARS


NCT01201356 PORTUGAL NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01566695 PORTUGAL CELGENE DRUG 2. RECRUITING 3 38618

YEARS N/A

MYELODYSPLAS-TIC

NCT01663402 PORTUGAL SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01682512 PORTUGAL BOEHRINGER INGELHEIM


YEARS 80


NCT01671007 PORTUGAL BOEHRINGER INGELHEIM


YEARS N/A

ATRIAL FIBRILLATION

NCT01393626 ROMANIA PFIZER DRUG 2. RECRUITING 2 27518

YEARS 75


NCT01628393 ROMANIA RECEPTOS DRUG 2. RECRUITING 2 21018

YEARS 55


NCT01697579 ROMANIA MERCK DRUG 2. RECRUITING 2 256 N/A 17

YEARS


NCT01201356 ROMANIA NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01479244 ROMANIA GALENA BIOLOGICAL 2. RECRUITING 3 70018


NCT01663402 ROMANIA SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01703208 ROMANIA MERCK DRUG 2. RECRUITING 3 4,00040

YEARS N/A DIABETES





























miN aGe

maX aGe CoNdiTioN

NCT01757405 ROMANIA BAXTER BIOLOGICAL 2. RECRUITING 3 3412

YEARS 65

YEARS HEMOPHILIA B

NCT01671007 ROMANIA BOEHRINGER INGELHEIM


YEARS N/A

ATRIAL FIBRILLATION

NCT01835431 RUSSIA NOVO NORDISK


YEARS DIABETES

NCT01840410 RUSSIA NOVARTIS DRUG 1. PLANNING 3 18712

YEARS N/A


NCT01928979 RUSSIA BAYER OTHER 1. PLANNING NA 15018

YEARS N/A

ATRIAL FIBRILLATION

NCT00625378 RUSSIA BAYER DRUG 2. RECRUITING 3 1,00016

YEARS N/A NEOPLASMS

NCT01201356 RUSSIA NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01479244 RUSSIA GALENA BIOLOGICAL 2. RECRUITING 3 70018


NCT01663402 RUSSIA SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01703208 RUSSIA MERCK DRUG 2. RECRUITING 3 4,00040

YEARS N/A DIABETES

NCT01708174 RUSSIA NOVARTIS DRUG 2. RECRUITING 3 109 N/A N/A MEDULLOBLAS-TOMA

NCT01757405 RUSSIA BAXTER BIOLOGICAL 2. RECRUITING 3 3412

YEARS 65

YEARS HEMOPHILIA B

NCT01846611 RUSSIA JANSSEN DRUG 2. RECRUITING 3 67018

YEARS N/A


NCT01868061 RUSSIA HOFFMANN-LA ROCHE


YEARS 75

YEARS ASTHMA

NCT01574703 RUSSIA PFIZER DRUG 2. RECRUITING 4 8,00018

YEARS 75


NCT01835431 SERBIA NOVO NORDISK


YEARS DIABETES

NCT01885208 SERBIA NOVO NORDISK


YEARS N/A DIABETES

NCT01628393 SERBIA RECEPTOS DRUG 2. RECRUITING 2 21018

YEARS 55


NCT01663402 SERBIA SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01703208 SERBIA MERCK DRUG 2. RECRUITING 3 4,00040

YEARS N/A DIABETES

NCT01838044 SINGAPORE PFIZER DRUG 1. PLANNING 4 36618

YEARS 75

YEARS BACK PAIN

NCT01663402 SINGAPORE SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01767467 SINGAPORE GSK BIOLOGICAL 2. RECRUITING 3 50218



(Return to Page 1)



























miN aGe

maX aGe CoNdiTioN

NCT01828099 SINGAPORE NOVARTIS DRUG 2. RECRUITING 3 34818


NCT01828112 SINGAPORE NOVARTIS DRUG 2. RECRUITING 3 23618


NCT01840410 SLOVAKIA NOVARTIS DRUG 1. PLANNING 3 18712

YEARS N/A


NCT01201356 SLOVAKIA NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLE-ROSIS

NCT01663402 SLOVAKIA SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A

ACUTECORONARY SYNDROME

NCT01703208 SLOVAKIA MERCK DRUG 2. RECRUITING 3 4,00040

YEARS N/A DIABETES

NCT01574703 SLOVAKIA PFIZER DRUG 2. RECRUITING 4 8,00018

YEARS 75


NCT01835431 SLOVENIA NOVO NORDISK


YEARS DIABETES

NCT01671007 SLOVENIA BOEHRINGER INGELHEIM


YEARS N/A

ATRIAL FIBRILLATION

NCT01840410 SOUTH AFRICA NOVARTIS DRUG 1. PLANNING 3 18712

YEARS N/A


NCT01393626 SOUTH AFRICA PFIZER DRUG 2. RECRUITING 2 27518

YEARS 75


NCT01201356 SOUTH AFRICA NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01663402 SOUTH AFRICA SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01703208 SOUTH AFRICA MERCK DRUG 2. RECRUITING 3 4,00040

YEARS N/A DIABETES

NCT01846611 SOUTH AFRICA JANSSEN DRUG 2. RECRUITING 3 67018

YEARS N/A


NCT01868061 SOUTH AFRICA HOFFMANN-LA ROCHE


YEARS 75

YEARS ASTHMA

NCT01574703 SOUTH AFRICA PFIZER DRUG 2. RECRUITING 4 8,00018

YEARS 75


NCT01835431 SPAIN NOVO NORDISK


YEARS DIABETES


YEARS N/A


NCT01751776 SPAIN BOEHRINGER INGELHEIM


YEARS 70

YEARS HEALTHY

NCT01393626 SPAIN PFIZER DRUG 2. RECRUITING 2 27518

YEARS 75


NCT01665391 SPAIN GENZYME DRUG 2. RECRUITING 2 8818

YEARS N/A

GLOMERULO-SCLEROSIS

NCT01697579 SPAIN MERCK DRUG 2. RECRUITING 2 256 N/A 17

YEARS































miN aGe

maX aGe CoNdiTioN

NCT01740336 SPAIN GENENTECH DRUG 2. RECRUITING 2 18018


NCT01762852 SPAIN GSK DRUG 2. RECRUITING 2 9418

YEARS 75


NCT01786668 SPAIN PFIZER DRUG 2. RECRUITING 2 20018

YEARS N/A


NCT00625378 SPAIN BAYER DRUG 2. RECRUITING 3 1,00016

YEARS N/A NEOPLASMS

NCT01201356 SPAIN NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01489111 SPAIN NOVO NORDISK



NCT01566695 SPAIN CELGENE DRUG 2. RECRUITING 3 38618

YEARS N/A

MYELODYSPLAS-TIC

NCT01663402 SPAIN SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A




YEARS 80


NCT01703208 SPAIN MERCK DRUG 2. RECRUITING 3 4,00040

YEARS N/A DIABETES

NCT01708174 SPAIN NOVARTIS DRUG 2. RECRUITING 3 109 N/A N/A MEDULLOBLAS-TOMA



YEARS N/A DIABETES

NCT01752322 SPAIN GRENENTHAL DRUG 2. RECRUITING 3 60018

YEARS N/A

POSTOPERATIVE PAIN

NCT01757405 SPAIN BAXTER BIOLOGICAL 2. RECRUITING 3 3412

YEARS 65

YEARS HEMOPHILIA B

NCT01767467 SPAIN GSK BIOLOGICAL 2. RECRUITING 3 50218






NCT01868061 SPAIN HOFFMANN-LA ROCHE


YEARS 75

YEARS ASTHMA

NCT01574703 SPAIN PFIZER DRUG 2. RECRUITING 4 8,00018

YEARS 75


NCT01697358 SPAIN MEDTRONIC DEVICE 2. RECRUITING 4 30018


NCT01511913 SPAIN BMS 2. RECRUITING NA 1,80018

YEARS N/A MELANOMA



YEARS N/A

ATRIAL FIBRILLATION

NCT01791361 SPAIN AMGEN OTHER 2. RECRUITING NA 45018

YEARS N/A

COLORECTAL CANCER

NCT01201356 SWEDEN NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS


(Return to Page 1)




























miN aGe

maX aGe CoNdiTioN

NCT01489111 SWEDEN NOVO NORDISK



NCT01566695 SWEDEN CELGENE DRUG 2. RECRUITING 3 38618

YEARS N/A

MYELODYSPLAS-TIC

NCT01663402 SWEDEN SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01703208 SWEDEN MERCK DRUG 2. RECRUITING 3 4,00040

YEARS N/A DIABETES

NCT01708174 SWEDEN NOVARTIS DRUG 2. RECRUITING 3 109 N/A N/A MEDULLOBLAS-TOMA

NCT01767467 SWEDEN GSK BIOLOGICAL 2. RECRUITING 3 50218


NCT01828099 SWEDEN NOVARTIS DRUG 2. RECRUITING 3 34818


NCT01671007 SWEDEN BOEHRINGER INGELHEIM


YEARS N/A

ATRIAL FIBRILLATION

NCT01840410 SWITZERLAND NOVARTIS DRUG 1. PLANNING 3 18712

YEARS N/A


NCT01697579 SWITZERLAND MERCK DRUG 2. RECRUITING 2 256 N/A 17

YEARS


NCT01201356 SWITZERLAND NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01489111 SWITZERLAND NOVO NORDISK



NCT01663402 SWITZERLAND SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01708174 SWITZERLAND NOVARTIS DRUG 2. RECRUITING 3 109 N/A N/A MEDULLOBLAS-TOMA

NCT01731600 SWITZERLAND NOVO NORDISK


YEARS HAEMOPHILIA A

NCT01828112 SWITZERLAND NOVARTIS DRUG 2. RECRUITING 3 23618


NCT01511913 SWITZERLAND BMS 2. RECRUITING NA 1,80018

YEARS N/A MELANOMA

NCT01598844 SWITZERLAND JENAVALVE DEVICE 2. RECRUITING NA 180 N/A N/A AORTIC STENOSIS

NCT01697579 TAIWAN MERCK DRUG 2. RECRUITING 2 256 N/A 17

YEARS


NCT00625378 TAIWAN BAYER DRUG 2. RECRUITING 3 1,00016

YEARS N/A NEOPLASMS

NCT01480479 TAIWAN CELLDEX DRUG 2. RECRUITING 3 44018


NCT01489111 TAIWAN NOVO NORDISK































miN aGe

maX aGe CoNdiTioN

NCT01560624 TAIWAN UNITED THERAPEUTICS


YEARS 75


NCT01560637 TAIWAN UNITED THERAPEUTICS


YEARS 75


NCT01641926 TAIWAN MERCK BIOLOGICAL 2. RECRUITING 3 1,40018

YEARS N/A


NCT01663402 TAIWAN SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01734785 TAIWAN BOEHRINGER INGELHEIM


YEARS N/A DIABETES

NCT01767467 TAIWAN GSK BIOLOGICAL 2. RECRUITING 3 50218


NCT01828099 TAIWAN NOVARTIS DRUG 2. RECRUITING 3 34818


NCT01480479 THAILAND CELLDEX DRUG 2. RECRUITING 3 44018


NCT01828099 THAILAND NOVARTIS DRUG 2. RECRUITING 3 34818


NCT01922102 THAILAND NOVARTIS DRUG 2. RECRUITING 3 47518

YEARS N/A

VISUAL IMPAIRMENT

NCT01895777 TURKEY BOEHRINGER INGELHEIM



NCT01928979 TURKEY BAYER OTHER 1. PLANNING NA 15018

YEARS N/A

ATRIAL FIBRILLATION

NCT01697579 TURKEY MERCK DRUG 2. RECRUITING 2 256 N/A 17

YEARS


NCT01201356 TURKEY NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS






YEARS HAEMOPHILIA A

NCT01767467 TURKEY GSK BIOLOGICAL 2. RECRUITING 3 50218


NCT01828099 TURKEY NOVARTIS DRUG 2. RECRUITING 3 34818


NCT01828112 TURKEY NOVARTIS DRUG 2. RECRUITING 3 23618


NCT00625378 UKRAINE BAYER DRUG 2. RECRUITING 3 1,00016

YEARS N/A NEOPLASMS

NCT01479244 UKRAINE GALENA BIOLOGICAL 2. RECRUITING 3 70018


NCT01663402 UKRAINE SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01731600 UKRAINE NOVO NORDISK


YEARS HAEMOPHILIA A


(Return to Page 1)



























miN aGe

maX aGe CoNdiTioN

NCT01757405 UKRAINE BAXTER BIOLOGICAL 2. RECRUITING 3 3412

YEARS 65

YEARS HEMOPHILIA B

NCT01907100 UK BOEHRINGER INGELHEIM



NCT01295827 UK MERCK DRUG 2. RECRUITING 1 1,06718


NCT01656395 UK MERCK DRUG 2. RECRUITING 2 1,47518

YEARS 65

YEARS ASTHMA

NCT01697579 UK MERCK DRUG 2. RECRUITING 2 256 N/A 17

YEARS


NCT01740336 UK GENENTECH DRUG 2. RECRUITING 2 18018


NCT01762852 UK GSK DRUG 2. RECRUITING 2 9418

YEARS 75


NCT01767090 UK ASTELLAS DRUG 2. RECRUITING 2 60018

YEARS 45

YEARS ENDOMETRIOSIS

NCT00625378 UK BAYER DRUG 2. RECRUITING 3 1,00016

YEARS N/A NEOPLASMS

NCT01201356 UK NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01479244 UK GALENA BIOLOGICAL 2. RECRUITING 3 70018


NCT01480479 UK CELLDEX DRUG 2. RECRUITING 3 44018


NCT01489111 UK NOVO NORDISK



NCT01560624 UK UNITED THERAPEUTICS


YEARS 75


NCT01560637 UK UNITED THERAPEUTICS


YEARS 75


NCT01566695 UK CELGENE DRUG 2. RECRUITING 3 38618

YEARS N/A

MYELODYSPLAS-TIC

NCT01663402 UK SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01682512 UK BOEHRINGER INGELHEIM


YEARS 80


NCT01708174 UK NOVARTIS DRUG 2. RECRUITING 3 109 N/A N/A MEDULLOBLAS-TOMA

NCT01731600 UK NOVO NORDISK


YEARS HAEMOPHILIA A

NCT01767467 UK GSK BIOLOGICAL 2. RECRUITING 3 50218


NCT01828099 UK NOVARTIS DRUG 2. RECRUITING 3 34818


NCT01828112 UK NOVARTIS DRUG 2. RECRUITING 3 23618































miN aGe

maX aGe CoNdiTioN

NCT01846611 UK JANSSEN DRUG 2. RECRUITING 3 67018

YEARS N/A


NCT01697358 UK MEDTRONIC DEVICE 2. RECRUITING 4 30018


NCT01511913 UK BMS 2. RECRUITING NA 1,80018

YEARS N/A MELANOMA

NCT01928459 USA NOVARTIS DRUG 1. PLANNING 1 5518


NCT01295827 USA MERCK DRUG 2. RECRUITING 1 1,06718


NCT01562275 USA GENENTECH DRUG 2. RECRUITING 1 10818

YEARS N/A NEOPLASMS

NCT01831427 USA GILEAD DRUG 2. RECRUITING 1 7418

YEARS 65

YEARS ULCERATIVE COLITIS



NCT01393626 USA PFIZER DRUG 2. RECRUITING 2 27518

YEARS 75


NCT01628393 USA RECEPTOS DRUG 2. RECRUITING 2 21018

YEARS 55



YEARS 65

YEARS ASTHMA

NCT01665391 USA GENZYME DRUG 2. RECRUITING 2 8818

YEARS N/A

GLOMERULO-SCLEROSIS

NCT01697579 USA MERCK DRUG 2. RECRUITING 2 256 N/A 17

YEARS


NCT01740336 USA GENENTECH DRUG 2. RECRUITING 2 18018


NCT01762852 USA GSK DRUG 2. RECRUITING 2 9418

YEARS 75


NCT01786668 USA PFIZER DRUG 2. RECRUITING 2 20018

YEARS N/A


NCT01843374 USA MEDIMMUNE DRUG 2. RECRUITING 2 18018


NCT01905657 USA MERCK BIOLOGICAL 2. RECRUITING 2 92018


NCT00625378 USA BAYER DRUG 2. RECRUITING 3 1,00016

YEARS N/A NEOPLASMS

NCT01201356 USA NOVARTIS DRUG 2. RECRUITING 3 5,00018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01479244 USA GALENA BIOLOGICAL 2. RECRUITING 3 70018


NCT01480479 USA CELLDEX DRUG 2. RECRUITING 3 44018


NCT01489111 USA NOVO NORDISK



NCT01560624 USA UNITED THERAPEUTICS


YEARS 75



(Return to Page 1)




























miN aGe

maX aGe CoNdiTioN

NCT01560637 USA UNITED THERAPEUTICS


YEARS 75


NCT01566695 USA CELGENE DRUG 2. RECRUITING 3 38618

YEARS N/A

MYELODYSPLAS-TIC

NCT01663402 USA SANOFI DRUG 2. RECRUITING 3 18,00040

YEARS N/A


NCT01682512 USA BOEHRINGER INGELHEIM


YEARS 80


NCT01682759 USA MERCK DRUG 2. RECRUITING 3 68018

YEARS N/A DIABETES


YEARS N/A DIABETES

NCT01708174 USA NOVARTIS DRUG 2. RECRUITING 3 109 N/A N/A MEDULLOBLAS-TOMA

NCT01731600 USA NOVO NORDISK


YEARS HAEMOPHILIA A



YEARS N/A DIABETES

NCT01757405 USA BAXTER BIOLOGICAL 2. RECRUITING 3 3412

YEARS 65

YEARS HEMOPHILIA B

NCT01767467 USA GSK BIOLOGICAL 2. RECRUITING 3 50218



YEARS 44

YEARS DIABETES




YEARS N/A


NCT01846611 USA JANSSEN DRUG 2. RECRUITING 3 67018

YEARS N/A


NCT01868061 USA HOFFMANN-LA ROCHE


YEARS 75

YEARS ASTHMA

NCT00867815 USA BAYER DRUG 2. RECRUITING 4 28440

YEARS N/A

OPTIC NEUROPATHY

NCT01574703 USA PFIZER DRUG 2. RECRUITING 4 8,00018

YEARS 75


NCT01697358 USA MEDTRONIC DEVICE 2. RECRUITING 4 30018




YEARS N/A DIABETES

NCT01478438 USA NOVIAN DEVICE 2. RECRUITING NA 6018

YEARS 80

YEARS MALIGNANT TUMOR

NCT01511913 USA BMS 2. RECRUITING NA 1,80018

YEARS N/A MELANOMA

NCT01839526 USA GENZYME DRUG 2. RECRUITING NA 100 5 YEARS 25

YEARS FABRY DISEASE


(Return to Page 1)

























(Return to Page 1)

COUNTRY

STUDIES OPENING A FIRST SITE

IN A NEW COUNTRY

STUDIES OPENING

ADDITIONAL SITES IN A COUNTRY

TOTAL TRIALS

ARGENTINA 3 7 10

AUSTRALIA 4 26 30

AUSTRIA 0 13 13

BELGIUM 9 17 26

BRAZIL 1 10 11

BULGARIA 1 12 13

CANADA 14 23 37

CHILE 1 2 3

CHINA 4 4 8

COLOMBIA 1 6 7

COSTA RICA 1 0 1

CROATIA 0 3 3

CZECH REPUBLIC

3 12 15

DENMARK 1 9 10

EGYPT 0 1 1

EL SALVADOR 0 2 2

ESTONIA 0 5 5

FINLAND 1 5 6

FRANCE 10 25 35

GEORGIA 0 2 2

GERMANY 11 30 41

GREECE 2 7 9

GUATEMALA 0 1 1

HONG KONG 2 5 7

HUNGARY 3 15 18

INDIA 4 3 7

IRELAND 0 3 3

ISRAEL 3 11 14

ITALY 8 23 31

JAPAN 7 10 17

STudy SiTeS by CouNTryThis table lists all countries with first-time and additional study sites that launched in the past week.

COUNTRY

STUDIES OPENING A FIRST SITE

IN A NEW COUNTRY

STUDIES OPENING

ADDITIONAL SITES IN A COUNTRY

TOTAL TRIALS

KOREA, SOUTH 4 13 17

LATVIA 1 3 4

LEBANON 1 3 4

LITHUANIA 2 6 8

MACEDONIA 0 1 1

MALAYSIA 0 6 6

MEXICO 7 4 11

NETHERLANDS 5 17 22

NEW ZEALAND 1 11 12

NORWAY 2 7 9

PANAMA 0 2 2

PERU 0 5 5

PHILIPPINES 2 1 3

POLAND 5 16 21

PORTUGAL 1 7 8

ROMANIA 2 9 11

RUSSIA 5 13 18

SERBIA 0 5 5

SINGAPORE 2 5 7

SLOVAKIA 0 5 5

SLOVENIA 0 2 2

SOUTH AFRICA 3 8 11

SPAIN 9 29 38

SWEDEN 2 9 11

SWITZERLAND 2 10 12

TAIWAN 5 11 16

THAILAND 4 3 7

TURKEY 2 9 11

UKRAINE 4 5 9

UNITED KINGDOM 11 25 36

UNITED STATES 35 44 79


ideNTifier1 SpoNSor Type2 STaTuS pHaSe3 SiZe (N) miN aGe maX aGe CoNdiTioN

NCT01691261 PFIZER BIOLOGICAL 1. PLANNING 1 1061

YEARS N/A


NCT01705158 ARCAGY DRUG 1. PLANNING 1 8818

YEARS N/A OVARIAN CANCER

NCT01728207 IMMUNOMEDICS DRUG 1. PLANNING 1 50 18 YEARS N/A LYMPHOMA

NCT01748864 ENDOCYTE DRUG 1. PLANNING 1 1018

YEARS N/A HEALTHY

NCT01771159 URO-RESEARCH DEVICE 1. PLANNING 1 1018

YEARS N/A

URINARY INCONTINENCE

NCT01792102 ONCOTHERA-PEUTICS


YEARS N/A

MULTIPLE MYELOMA

NCT01800175 OCULAR THERAPEUTIX


YEARS N/A HEALTHY


YEARS 65

YEARS INFECTIONS, BACTERIAL

NCT01805024 SANTHERA DRUG 1. PLANNING 1 24 5 YEARS 16

YEARS MUSCULAR DYSTROPHY


YEARS 55

YEARS SKIN INFECTIONS

NCT01812603 GW DRUG 1. PLANNING 1 618

YEARS N/A CANCER


YEARS N/A CANCER

NCT01817855 ASTRAZENECA DRUG 1. PLANNING 1 3418

YEARS 55

YEARS HEALTHY


YEARS 50

YEARS HEALTHY


YEARS 45

YEARS ULCERS, DUODENAL/GASTRIC


YEARS 45

YEARS ULCERS, DUODENAL/GASTRIC

NCT01852825 MERCK BIOLOGICAL 1. PLANNING 1 3418

YEARS 55

YEARS ALLERGIC RHINO-CONJUNCTIVITIS

NCT01866306 MERCK BIOLOGICAL 1. PLANNING 1 7318

YEARS 55

YEARS ASTHMA

NCT01870037 ION DRUG 1. PLANNING 1 1818

YEARS N/A

OVERACTIVE BLADDER

NCT01870102 DAEWON DRUG 1. PLANNING 1MISS-ING

20 YEARS

40 YEARS

HEALTHY





STudieS uNder plaNNiNG

This table lists all registered studies that are still under planning, have no site location listed and was first registered during the past year. About 10% of the studies listed as in the planning stage are replaced each week.


(See Studies under planning, Page 52)(Return to Page 1)

























NCT01877382 DAIICHI SANKYO DRUG 1. PLANNING 1 21 18 YEARS N/A LYMPHOMA

NCT01879722 TAKEDA DRUG 1. PLANNING 1 6018

YEARS 55

YEARS SCHIZOPHRENIA

NCT01881789 ONYX DRUG 1. PLANNING 1 59 18 YEARS N/A MULTIPLE MYELOMA

NCT01882296 AHN-GOOK DRUG 1. PLANNING 1 4020

YEARS 45

YEARS HEALTHY

NCT01890473 BMS DRUG 1. PLANNING 1 21618

YEARS N/A



YEARS 75

YEARS SOLID TUMOURS


YEARS 75

YEARS SOLID TUMOURS


YEARS 55

YEARS SYSTEMIC LUPUS ERYTHEMATOSUS


YEARS N/A TUMORS


YEARS 65

YEARS HEALTHY


YEARS 75

YEARS CHOLESTASIS, INTRAHEPATIC

NCT01900028 ASTRAZENECA PROCEDURE 1. PLANNING 1 4818



YEARS N/A SCHIZOPHRENIA


YEARS 45

YEARS HEALTHY


YEARS 55

YEARS HEALTHY

NCT01906307 LA JOLLA DRUG 1. PLANNING 1 2518

YEARS N/A

HEPATORENAL SYNDROME

NCT01907360 IRONSHORE DRUG 1. PLANNING 1 72 6 YEARS 17

YEARS ADHD


YEARS 55

YEARS HEALTHY


YEARS 55

YEARS HEALTHY

NCT01920061 PFIZER DRUG 1. PLANNING 1 85 18 YEARS N/A NEOPLASM



NCT01922050 LEO DRUG 1. PLANNING 1 58818

YEARS N/A

ACTINIC KERATOSIS

NCT01923389 PFIZER OTHER 1. PLANNING 1 2021

YEARS 70

YEARS DIABETES

NCT01924091 PARTNERSHIP FOR MICROBICIDES

DRUG 1. PLANNING 1MISS-ING

18 YEARS

N/A PHARMAOKINETICS

Studies under planning, from Page 51






























YEARS 55

YEARS HEALTHY


YEARS 55

YEARS HEALTHY


YEARS 55

YEARS ASTHMA


YEARS 70


NCT01927705 KANG STEM GENETIC 1. PLANNING 1 3020

YEARS 60

YEARS ATOPIC DERMATITIS

NCT01928394 BMS BIOLOGICAL 1. PLANNING 1 16018


NCT01928862 FERRING DRUG 1. PLANNING 1 75 9 YEARS 16

YEARS BOWEL PREPARATION


YEARS 65

YEARS ALOPECIA

NCT01929603 ASTRAZENECA PROCEDURE 1. PLANNING 1 1818



YEARS 55

YEARS GONOCOCCAL INFECTION

NCT01929746 BIOGEN BIOLOGICAL 1. PLANNING 1 5618

YEARS 55

YEARS HEALTHY


YEARS N/A HIV


YEARS 65

YEARS HCV INFECTION

NCT01930552 SANOFI DRUG 1. PLANNING 1 20 18 YEARS N/A NEOPLASM


YEARS 70

YEARS DIABETES


YEARS 55

YEARS HYPERHIDROSIS


YEARS 55

YEARS INFECTIONS, BACTERIAL


YEARS 70



YEARS 55

YEARS LPS CHALLENGE, NEUTROPHILS

NCT01937702 PROFIL OTHER 1. PLANNING 1 8018

YEARS 74

YEARS DIABETES


YEARS N/A

COLORECTAL CANCER


YEARS 80

YEARS RENAL IMPAIRMENT


YEARS N/A CANCER

































YEARS 65

YEARS ACNE VULGARIS





YEARS 55

YEARS HEALTHY


YEARS 35

YEARS HEALTHY

NCT01943838 SANOFI DRUG 1. PLANNING 1 2418

YEARS N/A NEOPLASM


YEARS N/A CANCER


YEARS 45



YEARS 50

YEARS TUBERCULOSIS

NCT01769027 CNS ONLUS DRUG 1. PLANNING 2 30 4 YEARS 40

YEARS PANDAS



YEARS 45

YEARS AUTISTIC DISORDER

NCT01798121 JHP BIOLOGICAL 1. PLANNING 2 9018

YEARS 60

YEARS TUBERCULOSIS IDENTIFICATION


YEARS N/A HEART FAILURE


YEARS 70

YEARS HUNTINGTON


YEARS N/A

CHRONIC MYELOID LEUKEMIA


YEARS 85

YEARS ALZHEIMER’

NCT01857232 ACACIA PHARMA LTD


YEARS N/A

CHEMOTHERAPY NASUEA/ VOMITING


YEARS N/A

ULCERATIVE COLITIS

NCT01864148 BIOGEN DRUG 1. PLANNING 2 39618

YEARS 58



YEARS N/A PROSTATE CANCER

NCT01887327 INFACARE DRUG 1. PLANNING 2 90 N/A 72

HOURS HYPERBILIRUBI-NEMIA

NCT01889797 PRECOG BIOLOGICAL 1. PLANNING 2 15018

YEARS N/A LYMPHOMA


YEARS N/A LEUKAEMIA, ACUTE

NCT01891331 VIAMET DRUG 1. PLANNING 2 4818

YEARS 65

YEARS CANDIDIASIS, VULVOVAGINAL





























NCT01891344 CLOVIS ONCOLOGY


YEARS N/A

PERITONEAL CANCER


YEARS N/A COUGH

NCT01899833 CELL>POINT RADIATION 1. PLANNING 2 6018

YEARS N/A



YEARS N/A UVEITIS

NCT01908192 SYNEURX DRUG 1. PLANNING 2 12612

YEARS 16

YEARS SCHIZOPHRENIA


YEARS N/A

CARCINOMA, HEPATOCELLULAR

NCT01912196 MSI DRUG 1. PLANNING 2 28621

YEARS 70


NCT01915472 IMMUNOMEDICS DRUG 1. PLANNING 2 5018

YEARS N/A

COLORECTAL CANCER

NCT01915940 FORSIGHT DRUG 1. PLANNING 2 12618

YEARS N/A

OCULAR HYPERTENSION


YEARS N/A

SURGICAL PROCEDURES


YEARS N/A HEART FAILURE

NCT01923181 NOVO NORDISK DRUG 1. PLANNING 2 60318

YEARS N/A DIABETES


YEARS 85

YEARS MYOSITIS

NCT01925261 ORTHOTROPHIX DRUG 1. PLANNING 2 12025

YEARS 75

YEARS KNEE OSTEOARTHRITIS


YEARS N/A

COLORECTAL CANCER

NCT01925950 SOLIGENIX DRUG 1. PLANNING 2 4018

YEARS N/A

GASTROINTESTINAL GRAFT VS HOST

NCT01927913 SHIRE DRUG 1. PLANNING 2 5018

YEARS N/A

METABOLIC DISEASES


YEARS 70

YEARS PEMPHIGUS VULGARIS

NCT01932762 MERCK DRUG 1. PLANNING 2 30 18 YEARS N/A HEPATITIS C


YEARS N/A MELANOMA


YEARS 85

YEARS GASTROPARESIS


YEARS N/A


NCT01939366 GRENENTHAL DRUG 1. PLANNING 2 35018

YEARS 80

YEARS DIABETES


YEARS 65

YEARS SCHIZOPHRENIA






























NCT01939899 MILLENNIUM DRUG 1. PLANNING 2 5818

YEARS N/A

FOLLICULAR LYMPHOMA

NCT01940601 TEVA DRUG 1. PLANNING 2 36 2 YEARS 17

YEARS SOLID TUMORS

NCT01941043 CERECOR DRUG 1. PLANNING 2 13518

YEARS 70



YEARS 80

YEARS CANCER


YEARS 70

YEARS ATRIAL FIBRILLATION

NCT01694966 COSMO DRUG 1. PLANNING 3 127050

YEARS 75

YEARS COLORECTAL CANCER

NCT01701349 OXIGENE DRUG 1. PLANNING 3 30018



YEARS N/A HIV

NCT01753180 MATRIZYME BIOLOGICAL 1. PLANNING 3MISS-ING

18 YEARS

80 YEARS

CHRONIC TOTAL OCCLUSIONS

NCT01762644 PERLE DRUG 1. PLANNING 3 60 8 YEARS 60

YEARS DIABETES

NCT01762657 PERLE DRUG 1. PLANNING 3 60 8 YEARS 60

YEARS DIABETES


YEARS N/A

FUNGAL INFECTIONS

NCT01787149 TSH DRUG 1. PLANNING 3 12920

YEARS N/A


NCT01803646 AURIS DRUG 1. PLANNING 3 33018

YEARS 75

YEARS ACUTE PERIPHERAL TINNITUS

NCT01814904 MITSUBISHI DRUG 1. PLANNING 3 140 2 YEARS 18

YEARS CHRONIC KIDNEY DISEASE




YEARS N/A PSORIASIS



NCT01829347 VITAL THER. BIOLOGICAL 1. PLANNING 3 12018

YEARS N/A

ACUTE ALCOHOLIC HEPATITIS

NCT01838551 CORTENDO DRUG 1. PLANNING 3 9018

YEARS N/A

ENDOGENOUS CUSHING’S SYNDROME

NCT01844856 TETRAPHASE DRUG 1. PLANNING 3 53618

YEARS N/A

INTRA-ABDOMINAL INFECTIONS


YEARS 70

YEARS INFECTION

NCT01847014 ACTELION DRUG 1. PLANNING 3 27518

YEARS 80






























NCT01848106 REGADO DRUG 1. PLANNING 3 1320018

YEARS N/A


NCT01850030 ABBOTT DRUG 1. PLANNING 3 106619

YEARS 41

YEARS FEMALE INFERTILITY

NCT01863680 MERCK SERONO


YEARS 45

YEARS EMBRYO TRANSFER

NCT01863732 NOVARTIS BIOLOGICAL 1. PLANNING 3 300 N/A N/A SPONDYLITIS, ANKYLOSING


YEARS 55



YEARS N/A

MULTIPLE SCLEROSIS

NCT01870362 CD PHARMA INDIA


YEARS 60

YEARS CHRONIC PERIODONTITIS


YEARS N/A

ACUTE HEART FAILURE

NCT01875874 VITAL THER. DRUG 1. PLANNING 3 12618

YEARS 65

YEARS FULMINANT HEPATIC FAILURE


YEARS N/A HYPERTENSION




YEARS N/A

PSORIATIC ARTHRITIS


YEARS 95

YEARS CORONARY ARTERY DISEASE


YEARS N/A COPD


YEARS N/A

CHRONIC RENAL FAILURE

NCT01882712 GALDERMA DRUG 1. PLANNING 3 84 18 YEARS N/A ERYTHEMA

NCT01884311 BIO BIOLOGICAL 1. PLANNING 3 45 2 YEARS 75

YEARS HYPER-IGM SYNDROME

NCT01888484 OCTAPHARMA BIOLOGICAL 1. PLANNING 3 64 2 YEARS 75

YEARS IMMUNE DEFICIENCY


YEARS 75

YEARS DIABETES

NCT01890798 GSK DRUG 1. PLANNING 3 55 5 YEARS N/A MUSCULAR DYSTROPHIES

NCT01890902 IMPRIMIS DRUG 1. PLANNING 3 35035

YEARS N/A

ACUTE PAIN OSTEOARTHRITIS


YEARS N/A MYELOMA

NCT01892345 ALEXION DRUG 1. PLANNING 3 9318

YEARS N/A

NEUROMYELITIS OPTICA

NCT01892436 NOVARTIS DRUG 1. PLANNING 3 515 N/A N/A PSORIATIC ARTHRITIS































YEARS 75

YEARS HYPERTENSION

NCT01896895 MERZ DRUG 1. PLANNING 3 6018

YEARS 80

YEARS BILATERAL BLEPHAROSPASM

NCT01898520 GW DRUG 1. PLANNING 3 72 8 YEARS 18

YEARS CEREBRAL PALSY


YEARS N/A COPD

NCT01901900 NOVARTIS BIOLOGICAL 1. PLANNING 3 454 N/A N/A RHEUMATOID ARTHRITIS

NCT01905592 TESARO DRUG 1. PLANNING 3 30618

YEARS N/A

BRCA2 GENE MUTATION

NCT01908933 AERIS DEVICE 1. PLANNING 3 25 40 YEARS N/A COPD

NCT01911364 CHIESI DRUG 1. PLANNING 3 3686 40 YEARS N/A COPD

NCT01911858 BBRAUN MEDICAL


YEARS N/A

THIRD DEGREE BURNS

NCT01912456 CSL BEHRING BIOLOGICAL 1. PLANNING 3 8012

YEARS N/A

HEREDITARY ANGIOEDEMA

NCT01913353 BAVARIAN NORDIC

BIOLOGICAL 1. PLANNING 3MISS-ING

18 YEARS

40 YEARS

HEALTHY

NCT01913405 BAXTER BIOLOGICAL 1. PLANNING 3 3012

YEARS 65

YEARS HEMOPHILIA A

NCT01913483 MEDICINES DRUG 1. PLANNING 3 390018

YEARS N/A

PERIPHERAL ENDOVASCULAR INTERVENTIONS

NCT01913847 HANMI DRUG 1. PLANNING 3 14420

YEARS N/A

SYSTOLIC DYSFUNCTION

NCT01917331 CHIESI DRUG 1. PLANNING 3 186340

YEARS N/A COPD

NCT01919801 SHIRE DRUG 1. PLANNING 3 11818

YEARS N/A

ANGIOTENSIN CON-VERTING ENZYME


YEARS 70

YEARS PEMPHIGUS

NCT01922258 OTSUKA DRUG 1. PLANNING 3 23055

YEARS 90

YEARS NERVOUS SYSTEM DISEASES


YEARS N/A GASTRIC CANCER




NCT01928771 ASTRAZENECA BIOLOGICAL 1. PLANNING 3 113418

YEARS 75

YEARS ASTHMA


YEARS N/A PARKINSON



NCT01934010 AURIS DRUG 1. PLANNING 3 33018

YEARS 76

YEARS ACUTE PERIPH-ERAL TINNITUS































YEARS 66

YEARS MENINGOCOCCAL DISEASE


YEARS N/A PSORIASIS


YEARS N/A LYMPHOMA


YEARS N/A COMMON COLD


YEARS 65



MONTHS 14

MONTHS MENINGOCOCCAL DISEASE

NCT01940848 BAYER DRUG 1. PLANNING 3 23718

YEARS N/A

IRRITABLE BOWEL SYNDROME

NCT01940887 OPHTHOTECH DRUG 1. PLANNING 3 62250

YEARS N/A



YEARS 50

YEARS

MULTIPLE SCLE-ROSIS (RELAPSING REMITTING)

NCT01942135 PFIZER DRUG 1. PLANNING 3 417 18 YEARS N/A BREAST CANCER

NCT01942733 H LUNDBECK DRUG 1. PLANNING 3 5018

YEARS 65

YEARS SLEEP DISTURBANCES

NCT01942785 H LUNDBECK DRUG 1. PLANNING 3 5018

YEARS 65

YEARS DEPRESSION

NCT01944059 TARGETED MEDICAL


YEARS 65

YEARS MIGRAINE

NCT01692470 JANSSEN DRUG 1. PLANNING 4 60 18 YEARS N/A HIV

NCT01758198 BMS BIOLOGICAL 1. PLANNING 4 30020

YEARS N/A


NCT01770223 MERCK DRUG 1. PLANNING 4 100 18 YEARS N/A HEPATITIS C

NCT01790828 PFIZER DRUG 1. PLANNING 4 600 N/A N/A HEMOPHILIA A

NCT01793142 PFIZER DRUG 1. PLANNING 4 3000 19 YEARS N/A POSTMENOPAUSAL

NCT01816633 CYTOMEDIX DEVICE 1. PLANNING 4 38018

YEARS N/A

DIABETIC FOOT ULCERS

NCT01816672 CYTOMEDIX DEVICE 1. PLANNING 4 28018

YEARS N/A

DIABETIC FOOT ULCER

NCT01817543 CYTOMEDIX DEVICE 1. PLANNING 4 385 18 YEARS N/A LEG ULCER

NCT01819142 CYTOMEDIX DEVICE 1. PLANNING 4 400 18 YEARS N/A PRESSURE ULCER

NCT01824576 ADVANCED CIRCULATORY


YEARS N/A

CEREBRAL PERFUSION

NCT01834937 INSIGHTEC DEVICE 1. PLANNING 4 50 18 YEARS N/A PAIN METASTASES

NCT01841437 GLAUKOS DEVICE 1. PLANNING 4 500 N/A N/A GLAUCOMA

NCT01841450 GLAUKOS DEVICE 1. PLANNING 4 360 22 YEARS N/A GLAUCOMA


YEARS 75

YEARS CHRONIC VENOUS INSUFFICIENCY

































NCT01856569 PFIZER OTHER 1. PLANNING 4 15018

YEARS 75

YEARS ANKYLOSING SPONDYLITIS

NCT01863849 OMNINVEST BIOLOGICAL 1. PLANNING 4 120 18 YEARS N/A INFLUENZA

NCT01864200 BTS BIOLOGICAL 1. PLANNING 4 23214

YEARS N/A

AGKISTRODON CONTORTRIX ENVENOMATION

NCT01870843 XIAN-JANSSEN DRUG 1. PLANNING 4 26018

YEARS 65


NCT01884337 BMS DRUG 1. PLANNING 4 750 18 YEARS N/A ANTICOAGULATION


YEARS N/A

ATRIAL FIBRILLATION

NCT01887483 DANISCO DIETARY SUP.

1. PLANNING 4 23018

YEARS 65

YEARS IRRITABLE BOWEL SYNDROME

NCT01896479 EXELIXIS DRUG 1. PLANNING 4 112 18 YEARS N/A THYROID CANCER

NCT01897766 PFIZER DRUG 1. PLANNING 4 500 3 YEARS 20

YEARS SMALL FOR GESTATIONAL AGE

NCT01907854 NOVO NORDISK DRUG 1. PLANNING 4 39618

YEARS N/A DIABETES

NCT01909934 MILLENNIUM DRUG 1. PLANNING 4 4518

YEARS N/A LYMPHOMA

NCT01913054 JIANGSU NHWA DRUG 1. PLANNING 4 245045

YEARS 75

YEARS SAFETY OF GASTROSCOPY

NCT01915914 GSK DRUG 1. PLANNING 4 120 1 YEAR 18 YEARS SKIN DISEASES


YEARS 65


NCT01916226 GSK DRUG 1. PLANNING 4 648 18 YEARS N/A RHINITIS

NCT01922141 NOVARTIS DRUG 1. PLANNING 4 1395 65 YEARS N/A HYPERTENSION


YEARS N/A

CHRONIC INTRACTABLE PAIN

NCT01926015 MERCK BIOLOGICAL 1. PLANNING 4 190 42 DAYS 76 DAYS ROTAVIRUS DISEASE

NCT01930708 BIOGEN DRUG 1. PLANNING 4 108018

YEARS N/A

MULTIPLE SCLEROSIS

NCT01936870 PFIZER DRUG 1. PLANNING 4 2000 N/A N/A OVERACTIVE BLADDER (OAB)

NCT01937325 THE ALFRED DRUG 1. PLANNING 4 20 16 YEARS 70 YEARS CYSTIC FIBROSIS



YEARS 75

YEARS COPD

NCT01683305 SILBIOTECH 1. PLANNING NA 500 18 YEARS N/A TUMORS

NCT01685047 ST JUDE 1. PLANNING NA 47018

YEARS N/A


NCT01688011 CELGENE 1. PLANNING NA 1500 18 YEARS N/A LEUKEMIA

NCT01700543 ZIMMER PROCEDURE 1. PLANNING NA 16018

YEARS 80

YEARS RHEUMATOID ARTHRITIS

NCT01719263 UPTAKE DEVICE 1. PLANNING NA 69 40 YEARS 75 YEARS EMPHYSEMA

































NCT01728103 GEN-PROBE DEVICE 1. PLANNING NA 210016

YEARS N/A

TRICHOMONAS INFECTIONS

NCT01728714 ASTRAZENECA 1. PLANNING NA 250 18 YEARS N/A DIABETES

NCT01733368 ST JUDE 1. PLANNING NA 200 18 YEARS N/A HEART FAILURE

NCT01741025 SI-BONE DEVICE 1. PLANNING NA 10021

YEARS 70

YEARS SACROILIAC JOINT PAIN

NCT01751139 GSK PROCEDURE 1. PLANNING NA 15006

MONTHS N/A DENGUE VACCINES

NCT01772225 GSK OTHER 1. PLANNING NA 900 18 YEARS N/A LUNG CANCER




NCT01781416 ASTRAZENECA 1. PLANNING NA 80050

YEARS N/A

CARDIOVASCULAR RISK

NCT01793324 ASTRAZENECA 1. PLANNING NA 60018

YEARS N/A

DEPRESSIVE DISORDER

NCT01795326 ASTRAZENECA 1. PLANNING NA 800 N/A N/A DEPRESSIVE DISORDER

NCT01802788 ST JUDE DEVICE 1. PLANNING NA 105018

YEARS N/A

AORTIC VALVE STENOSIS

NCT01818388 ZOLL CIRCULATION

DEVICE 1. PLANNING NA 5018

YEARS N/A CARDIAC ARREST

NCT01818947 ASTRAZENECA 1. PLANNING NA 200 18 YEARS N/A LUNG CANCER

NCT01824563 ADVANCED BIONICS

OTHER 1. PLANNING NA 12018

YEARS N/A HEARING LOSS

NCT01829061 QUOTIENT 1. PLANNING NA 165 18 YEARS N/A DIABETES

NCT01829152 VERIZON DEVICE 1. PLANNING NA 100 18 YEARS N/A HEART FAILURE

NCT01832493 MEDTRONIC DEVICE 1. PLANNING NA 60 18 YEARS N/A HEART FAILURE

NCT01832714 NEURO KINETICS 1. PLANNING NA 18019

YEARS 45

YEARS CONCUSSION, SEVERE

NCT01834222 PFIZER BIOLOGICAL 1. PLANNING NA 60050

YEARS N/A

PNEUMOCOCCAL DISEASE

NCT01838980 MOTUS GI DEVICE 1. PLANNING NA 50 50 YEARS 69 YEARS COLON CLEANSING

NCT01845103 CARDIOGENESIS 1. PLANNING NA 22 18 YEARS N/A ANGINA

NCT01850199 PARC TAULI OTHER 1. PLANNING NA 2018

YEARS 46

YEARS GESTATIONAL DIABETES

NCT01851772 XOFT DEVICE 1. PLANNING NA 5 N/A N/A CERVICAL CANCER

NCT01859572 RENEURON 1. PLANNING NA 200 18 YEARS N/A MOTOR ACTIVITY

NCT01860092 SECOND SIGHT 1. PLANNING NA 5325

YEARS N/A

RETINITIS PIGMENTOSA

NCT01866475 VIDACARE DEVICE 1. PLANNING NA 12021

YEARS N/A

INTRAOSSEOUS VASCULAR ACCESS

NCT01869101 TETHYS 1. PLANNING NA 560 18 YEARS N/A PREDIABETES

NCT01878149 BAXANO 1. PLANNING NA 4018

YEARS N/A

DEGENERATIVE DISC


































NCT01885572 PFM DEVICE 1. PLANNING NA 26018

YEARS 75

YEARS BREAST RECONSTRUCTION

NCT01885585 BMS DRUG 1. PLANNING NA 3000 19 YEARS N/A THROMBOEMBOLISM

NCT01885598 BMS DRUG 1. PLANNING NA 300019

YEARS N/A

ATRIAL FIBRILLATION

NCT01887639 ASTRAZENECA 1. PLANNING NA 200 18 YEARS 75 YEARS DEPRESSION

NCT01890447 GSK OTHER 1. PLANNING NA 700 18 YEARS N/A PERTUSSIS

NCT01892319 NOVO NORDISK DRUG 1. PLANNING NA 3075 N/A N/A DIABETES

NCT01896089 BIOLOGICTX 1. PLANNING NA 10018

YEARS N/A

KIDNEY TRANSPLANTS

NCT01899573 GUIDED DELIVERY


YEARS N/A

MITRAL REGURGITATION

NCT01900691 COOK DEVICE 1. PLANNING NA 130 18 YEARS N/A STENTS

NCT01903187 ST JUDE DEVICE 1. PLANNING NA 590 18 YEARS 80 YEARS HYPERTENSION

NCT01906294 IMS DRUG 1. PLANNING NA 12000 18 YEARS N/A DIABETES

NCT01907048 BAYER BEHAVIORAL 1. PLANNING NA 4000 18 YEARS N/A ANTICOAGULATION

NCT01907828 ST JUDE DEVICE 1. PLANNING NA 100 18 YEARS N/A CARDIAC ABLATION

NCT01910896 MERZ DEVICE 1. PLANNING NA 120 18 YEARS N/A SURGERY SCARS

NCT01911078 ST JUDE PROCEDURE 1. PLANNING NA 60 18 YEARS 80 YEARS HYPERTENSION

NCT01911143 MEMED 1. PLANNING NA 325 1 MONTH 18

YEARS ARTHRITIS, INFECTIOUS

NCT01913613 DC DEVICE DEVICE 1. PLANNING NA MISS-ING

40 YEARS N/A HEART FAILURE

NCT01915888 GSK OTHER 1. PLANNING NA 1 N/A 5 YEARS GASTROENTERITIS

NCT01917968 BOSTON SCIENTIFIC


YEARS N/A PELVIC PROLAPSE

NCT01919320 SYNCARDIA DEVICE 1. PLANNING NA 302 N/A N/A VENTRICULAR FAILURE


YEARS 64


NCT01925794 CELONOVA DEVICE 1. PLANNING NA 29618

YEARS N/A


NCT01929291 GSK BIOLOGICAL 1. PLANNING NA 60011

YEARS 64

YEARS BOOSTRIX VACCINATION

NCT01933945 BAYER PROCEDURE 1. PLANNING NA 1670 N/A N/A CARCINOMA, HEPATOCELLULAR

NCT01934452 PFIZER DRUG 1. PLANNING NA 12018

YEARS 80

YEARS RENAL CELL CARCINOMA

NCT01936636 GALENA DRUG 1. PLANNING NA 2500 18 YEARS N/A CANCER PAIN

NCT01939249 BIOTRONIK DEVICE 1. PLANNING NA 58518

YEARS 80

YEARS CORONARY ARTERY DISEASE

NCT01940328 ECHOSENSE DEVICE 1. PLANNING NA 15018

YEARS N/A

PULMONARY EDEMA

NCT01940770 ASTRAZENECA 1. PLANNING NA 1100 N/A N/A DIABETES



































miN aGe

maX aGe CoNdiTioN


DRUG 5. SUSPENDED 2 16 1 YEAR 11

YEARS VENOUS THROMBOEMBOLISM


DRUG 5. SUSPENDED 2 12 1 YEAR 11

YEARS VENOUS THROMBOEMBOLISM

NCT01901146 AMGEN DRUG 5. SUSPENDED 3 588 N/A N/A BREAST CANCER

NCT01366651 JANSSEN DRUG 7. TERMINATED 1 1 N/A 1 YEAR MENINGITIS

NCT01627002 PROTAFFIN BIOLOGICAL 7. TERMINATED 1 4918

YEARS 65

YEARS HEALTHY VOLUNTEERS

NCT01793649 GILEAD DRUG 7. TERMINATED 1 7 18 YEARS 45 YEARS COPD

NCT01214174 ICON DRUG 7. TERMINATED 2 4240

YEARS N/A

OCULAR INFLAMMATION

NCT01554176 MERCK DRUG 7. TERMINATED 2 12921

YEARS 64


NCT01103063 PFIZER DRUG 7. TERMINATED 3 5,04416

YEARS 35

YEARS

PREVENTIVE TREATMENT PREGNANCY


YEARS N/A

OVERACTIVE BLADDER

NCT00519194 ST JUDE DEVICE 7. TERMINATED NA 11218

YEARS 80

YEARS ATRIAL FIBRILLATION

NCT01363921 GAMBRO DEVICE 7. TERMINATED NA 1018

YEARS N/A

CHRONIC KIDNEY FAILURE

NCT01832103 MERCK DRUG 8. WITHDRAWN 1 018

YEARS 75

YEARS RENAL INSUFFICIENCY

NCT01491659 PFIZER DIETARY SUP.

8. WITHDRAWN 4 018

YEARS 70

YEARS DIARRHOEA

NCT01727271 MERCK DRUG 8. WITHDRAWN 4 0 18 YEARS N/A HEPATITIS B

STudieS eNded or HalTed

This table lists studies that were terminated, suspended or withdrawn in the past week.


Clinical Trial Magnifier Limited: Managing Director, Johan PE Karlberg fdanews: president, Cynthia Carter; Content director: Dan Landrigan; executive editor: Meg BryantCopyright © 2013 by Clinical Trial Magnifier. All rights reserved. Clinical Trial Magnifier Weekly is produced jointly by Clinical Trial Magni-fier Limited, which is responsible for the content, and FDAnews, which is responsible for production and distribution. Clinical Trial Magni-fier Weekly (ISSN 2306-8388) monitors all the essential changes made in the U.S. trial registry for industry-sponsored clinical studies. It is published weekly, 52 issues. Price for nonprofit, academic, government, hospital, and study site subscribers, $697. Price for for-profit, in-dustry, and clinical research organizations, $1,297. For site license pricing, contact Nelly Valentin, [email protected]. Photocopying or reproducing in any form, including electronic or facsimile transmission, scanning or electronic storage is a violation of federal copyright law and is strictly prohibited without the publisher’s express written permission.

300 N. Washington St., Suite 200 • Falls Church, VA 22046-3431 • Phone: (888) 838-5578 • +1 (703) 538-7600 • Fax: +1 (703) 538-7676www.fdanews.com

Customer Service: Kim Williams editorial: Dan Landrigan ad Sales: Jim Desborough Content Sales: Nelly Valentin(888) 838-5578 • +1 (703) 538-7600 (703) 538-7649 (703) 538-7647 (703) [email protected] [email protected] [email protected] [email protected]


NCT01942200 ONKOVIS 1. PLANNING NA 350 N/A N/A CARCINOMA

NCT01944618 BMS DRUG 1. PLANNING NA 5000 18 YEARS 75 YEARS DIABETES

















mailto:[email protected]

http://www.fdanews.com

http://www.fdanews.com







Documents

INsIde thIs Issue - PRWebww1.prweb.com/prfiles/2013/10/04/11197922/CTM_092613web.pdf · OxOnc Development, Proximagen, Skeletal Dynamics and Strati-Health. ... Kline, Hoffmann-La